[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 15675
1. Jankulov A, Uchikov A, Paskalev G, Mourdjav K, Prisadov G, Hristov G, Chapkanov A, Ouzunuva V, Dimitrov I, Batashki A: [The role of video-assisted thorascopy in determination of surgical behaviour in patients with non-small cell lung cancer and pleural effusion]. Khirurgiia (Sofiia); 2009;(2-3):41-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The role of video-assisted thorascopy in determination of surgical behaviour in patients with non-small cell lung cancer and pleural effusion].
  • INTRODUCTION: Although of introduction of new methods for diagnosis in patients with lung cancer and pleural effusion, VATS remain "the gold standart".
  • AIM OF THE STUDY: The aim of this study is to present our experience in using VATS for diagnosis and surgical behaviour in patients with lung cancer and pleural effusion.
  • MATERIALS AND METHODS: Between January 2007 - March 2009 in Department of thoracic and abdominal surgery UMBAL St. George Plovdiv we made 62 VATS in patients with lung cancer and pleural effusion.
  • [MeSH-major] Carcinoma, Non-Small-Cell Lung / diagnosis. Carcinoma, Non-Small-Cell Lung / surgery. Lung Neoplasms / diagnosis. Lung Neoplasms / surgery. Pleural Effusion / diagnosis. Pleural Effusion / surgery. Thoracic Surgery, Video-Assisted


2. Rubio Tapia A, Ramírez Arias F, Angeles Angeles A, Uscanga L: [Peutz-Jeghers syndrome]. Rev Gastroenterol Mex; 2005 Jul-Sep;70(3):291-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Síndrome de Peutz-Jeghers.
  • MATERIAL AND METHODS: A retrospective review of all the discharge diagnosis was doing between January 1987 to February 2004.
  • The diagnosis of Peutz-Jeghers syndrome was made on clinical and anatomical grounds.
  • PRESENTATION OF CASES: Eight patients with the Peutz-Jeghers syndrome were investigated, five women and three men.
  • The median of time at diagnosis was 31 years-old (range, 26-37).
  • The major abdominal symptoms were abdominal pain, GI bleeding, intestinal obstruction, weight loss and intussusception.
  • One case of small-bowel cancer and one of serous cystadenoma of the ovary were detected.

  • Genetic Alliance. consumer health - Peutz Jeghers syndrome.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17063785.001).
  • [ISSN] 0375-0906
  • [Journal-full-title] Revista de gastroenterología de México
  • [ISO-abbreviation] Rev Gastroenterol Mex
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Mexico
  • [Number-of-references] 19
  •  go-up   go-down


3. Hakimi AA, Faiena I, Kaleya RN, Ghavamian R: Retroperitoneal Castleman's disease. Urology; 2010 Dec;76(6):1379
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 56-year-old postmenopausal woman with a history of colon cancer status after left hemicolectomy presented to our institution with abdominal pain, early satiety, and weight loss.
  • [MeSH-minor] Adenocarcinoma / surgery. Colonic Neoplasms / surgery. Diagnosis, Differential. Female. Humans. Liposarcoma / diagnosis. Lymph Node Excision. Middle Aged. Nephrectomy. Retroperitoneal Neoplasms / diagnosis. Retroperitoneal Space

  • Genetic Alliance. consumer health - Castleman's Disease.
  • MedlinePlus Health Information. consumer health - After Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20138654.001).
  • [ISSN] 1527-9995
  • [Journal-full-title] Urology
  • [ISO-abbreviation] Urology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


Advertisement
4. Larson DW, Boostrom SY, Cima RR, Pemberton JH, Larson DR, Dozois EJ: Laparoscopic surgery for rectal cancer: short-term benefits and oncologic outcomes using more than one technique. Tech Coloproctol; 2010 Jun;14(2):125-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic surgery for rectal cancer: short-term benefits and oncologic outcomes using more than one technique.
  • BACKGROUND: Several minimally invasive techniques have now been described for rectal cancer resection.
  • Our aim was to review outcomes in patients undergoing minimally invasive surgery for rectal cancer at our institution in the current era.
  • METHODS: A retrospective analysis was done to assess short-term benefits and oncologic outcomes in patients undergoing minimally invasive surgery for rectal cancer between 2004 and 2007.
  • RESULTS: One-hundred consecutive patients (61 men, median age 62) with a median follow-up of 1.8 years were identified.
  • Seventy-two patients underwent anterior resection, 27 an abdominal perineal resection, and 1 a total proctocolectomy.
  • Tumor stage was stage 1 (21%), stage 2 (17%), stage 3 (56%), and stage 4 (6%).
  • CONCLUSION: Both minimally invasive techniques used achieved excellent oncologic results in patients with rectal cancer.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Cohort Studies. Disease-Free Survival. Female. Hospitalization. Humans. Male. Middle Aged. Neoplasm Staging. Retrospective Studies. Survival Rate. Treatment Outcome

  • Genetic Alliance. consumer health - Rectal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Am Coll Surg. 2007 Feb;204(2):291-307 [17254934.001]
  • [Cites] Lancet Oncol. 2005 Jul;6(7):477-84 [15992696.001]
  • [Cites] Ann Surg. 2007 Oct;246(4):655-62; discussion 662-4 [17893502.001]
  • [Cites] N Engl J Med. 2004 May 13;350(20):2050-9 [15141043.001]
  • [Cites] Ann Surg Oncol. 2009 Jun;16(6):1480-7 [19290486.001]
  • [Cites] Dis Colon Rectum. 2007 Apr;50(4):464-71 [17195085.001]
  • [Cites] Surg Endosc. 2006 Aug;20(8):1197-202 [16865622.001]
  • [Cites] Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005200 [17054246.001]
  • [Cites] Ann Surg. 2009 Jul;250(1):54-61 [19561481.001]
  • [Cites] Lancet. 2005 May 14-20;365(9472):1718-26 [15894098.001]
  • [Cites] ANZ J Surg. 2007 Jul;77(7):508-16 [17610681.001]
  • [Cites] J Clin Oncol. 2007 Jul 20;25(21):3061-8 [17634484.001]
  • [Cites] Ann Surg. 1998 Jun;227(6):800-11 [9637543.001]
  • [Cites] J Clin Oncol. 2005 Dec 1;23(34):8664-70 [16260700.001]
  • [Cites] Dig Surg. 2007;24(5):367-74 [17785982.001]
  • [Cites] Ann Surg. 2005 Dec;242(6):890-5, discussion 895-6 [16327499.001]
  • [Cites] Surg Endosc. 2004 Aug;18(8):1211-5 [15457380.001]
  • [Cites] Br J Surg. 2007 Dec;94(12):1555-61 [17668915.001]
  • [Cites] Surg Endosc. 2005 Nov;19(11):1460-7 [16206013.001]
  • [Cites] Int J Colorectal Dis. 2007 Apr;22(4):367-72 [16786316.001]
  • [Cites] Dis Colon Rectum. 1999 Jul;42(7):930-9 [10411441.001]
  • [Cites] Cochrane Database Syst Rev. 2008 Apr 16;(2):CD003432 [18425886.001]
  • [Cites] Ann Surg Oncol. 2006 Mar;13(3):413-24 [16450220.001]
  • [Cites] Surg Endosc. 2004 Feb;18(2):281-9 [14691716.001]
  • [Cites] Dis Colon Rectum. 2007 Dec;50(12):2047-53 [17906896.001]
  • (PMID = 20405303.001).
  • [ISSN] 1128-045X
  • [Journal-full-title] Techniques in coloproctology
  • [ISO-abbreviation] Tech Coloproctol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


5. Song Y, Liu QD, Zhou NX, Zhang WZ, Wang DJ: Diagnosis and management of autoimmune pancreatitis: experience from China. World J Gastroenterol; 2008 Jan 28;14(4):601-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnosis and management of autoimmune pancreatitis: experience from China.
  • The main clinical manifestations included intermittent or progressive jaundice in 18 cases (72%), abdominal pain in 11 (44%), weight loss in 10 (40%), and 3 cases had no symptoms.
  • No pancreatic cancer occurred during a mean 46-mo follow-up period.
  • CONCLUSION: AIP patients always are subjected to mistaken diagnosis of pancreatic cancer and an unnecessary surgical exploration, due to its similarity in clinical features with pancreatic cancer.
  • The differential diagnosis with high index of suspicion of AIP would improve the diagnostic accuracy for AIP.
  • [MeSH-major] Autoimmune Diseases / diagnosis. Autoimmune Diseases / drug therapy. Pancreatitis, Chronic / diagnosis. Pancreatitis, Chronic / drug therapy. Steroids / therapeutic use

  • Genetic Alliance. consumer health - Pancreatitis.
  • MedlinePlus Health Information. consumer health - Autoimmune Diseases.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Gastrointest Surg. 2005 Jan;9(1):6-10 [15773046.001]
  • [Cites] Clin Chem. 2007 Sep;53(9):1700-5 [17712006.001]
  • [Cites] Pancreas. 2005 May;30(4):355-8 [15841047.001]
  • [Cites] Chin J Dig Dis. 2005;6(2):87-92 [15904427.001]
  • [Cites] World J Gastroenterol. 2005 Sep 21;11(35):5577-81 [16222761.001]
  • [Cites] Gastroenterology. 2005 Dec;129(6):2118-20; discussion 2120 [16344083.001]
  • [Cites] Gastroenterology. 2001 Feb;120(3):682-707 [11179244.001]
  • [Cites] N Engl J Med. 2001 Mar 8;344(10):732-8 [11236777.001]
  • [Cites] Gastroenterology. 2002 May;122(5):1264-9 [11984513.001]
  • [Cites] Gut. 2002 Jul;51(1):1-4 [12077078.001]
  • [Cites] Am J Surg Pathol. 2003 Jan;27(1):110-20 [12502933.001]
  • [Cites] J Gastrointest Surg. 2003 Jan;7(1):129-37; discussion 137-9 [12559194.001]
  • [Cites] Gut. 2003 May;52(5):683-7 [12692053.001]
  • [Cites] Ann Surg. 2003 Jun;237(6):853-8; discussion 858-9 [12796582.001]
  • [Cites] Pancreas. 2003 Jul;27(1):1-13 [12826899.001]
  • [Cites] J Gastroenterol. 2003;38(10):982-4 [14614606.001]
  • [Cites] Gastroenterology. 2003 Nov;125(5):1557-8 [14628815.001]
  • [Cites] Am J Gastroenterol. 2003 Dec;98(12):2694-9 [14687819.001]
  • [Cites] Gastroenterology. 2004 Apr;126(4):1214 [15057766.001]
  • [Cites] Dig Dis Sci. 1995 Jul;40(7):1561-8 [7628283.001]
  • [Cites] Dig Dis Sci. 1997 Jul;42(7):1458-68 [9246047.001]
  • [Cites] Am J Dig Dis. 1961 Jul;6:688-98 [13746542.001]
  • [Cites] Virchows Arch. 2004 Dec;445(6):552-63 [15517359.001]
  • [Cites] World J Gastroenterol. 2006 Mar 21;12(11):1810-2 [16586561.001]
  • [Cites] World J Gastroenterol. 2006 Apr 28;12(16):2487-96 [16688792.001]
  • [Cites] World J Gastroenterol. 2006 May 14;12(18):2919-22 [16718819.001]
  • [Cites] Pancreas. 2006 Jul;33(1):13-9 [16804407.001]
  • [Cites] Clin Gastroenterol Hepatol. 2006 Aug;4(8):1010-6; quiz 934 [16843735.001]
  • [Cites] J Gastroenterol. 2006 Jul;41(7):613-25 [16932997.001]
  • [Cites] J Gastroenterol. 2006 Jul;41(7):626-31 [16932998.001]
  • [Cites] World J Gastroenterol. 2006 Oct 14;12(38):6225-8 [17036401.001]
  • [Cites] Am J Surg Pathol. 2006 Dec;30(12):1537-45 [17122509.001]
  • [Cites] Am J Gastroenterol. 2006 Nov;101(11):2493-500 [17029619.001]
  • [Cites] Mod Pathol. 2007 Jan;20(1):23-8 [16980948.001]
  • [Cites] N Engl J Med. 2006 Dec 21;355(25):2670-6 [17182992.001]
  • [Cites] Gastrointest Endosc. 2007 Jan;65(1):99-108 [17185087.001]
  • [Cites] Pancreas. 2007 Aug;35(2):156-61 [17632322.001]
  • [Cites] Hepatology. 2007 Aug;46(2):463-71 [17634963.001]
  • [Cites] Gut. 2005 May;54(5):581-3 [15831898.001]
  • (PMID = 18203294.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Steroids
  • [Other-IDs] NLM/ PMC2681153
  •  go-up   go-down


6. Okamura H, Fujiwara H, Ichikawa D, Okamoto K, Kikuchi S, Kubota T, Ikoma H, Nakanishi M, Ochiai T, Sakakura C, Kokuba Y, Taniguchi H, Sonoyama T, Otsuji E: [A case of multiple hepatic metastases of gastric cancer that showed complete regression by systemic chemotherapy using paclitaxel and UFT-E]. Gan To Kagaku Ryoho; 2009 Jun;36(6):987-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of multiple hepatic metastases of gastric cancer that showed complete regression by systemic chemotherapy using paclitaxel and UFT-E].
  • We report a case of gastric cancer with simultaneous multiple liver metastasis that was successfully treated by paclitaxel and UFT-E.
  • A 54-year-old man with gastric cancer was admitted to our hospital for further examination and treatment.
  • A type III gastric cancer was located in the lower to middle part of the gastric body.
  • Abdominal CT revealed multiple liver metastases and lymph node metastases.
  • Postoperative pathological diagnosis was stage IV(a type 3 tumor( 78x65 mm), pT3, por 2, INF g, ly3, v0, pN2(+)(26/ 28), H1(bilobular multiple metastases), CY0, P0).
  • Four months after the operation, abdominal computed tomography(CT)showed a remarkable reduction of the multiple liver metastases, and the serum levels of tumor markers(CEA, CA19-9)were reduced.
  • Five months after the operation, the serum levels of tumor markers elevated again.
  • Seven months after the operation, abdominal CT showed a complete regression of the multiple liver metastasis, and the serum levels of tumor markers were also reduced within the normal range.
  • Paclitaxel or paclitaxel combined with UFT-E might be an effective regimen as second- or third-line chemotherapy for the liver metastases of gastric cancer.
  • [MeSH-minor] Antineoplastic Agents, Phytogenic / administration & dosage. Biomarkers, Tumor / blood. CA-19-9 Antigen / blood. Carcinoembryonic Antigen / blood. Humans. Lymphatic Metastasis. Male. Middle Aged. Paclitaxel / administration & dosage. Tegafur / administration & dosage. Tomography, X-Ray Computed. Uracil / administration & dosage

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. TAXOL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19542721.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Phytogenic; 0 / Biomarkers, Tumor; 0 / CA-19-9 Antigen; 0 / Carcinoembryonic Antigen; 1548R74NSZ / Tegafur; 56HH86ZVCT / Uracil; P88XT4IS4D / Paclitaxel; 1-UFT protocol
  •  go-up   go-down


7. Kent R, Stacey S, Kindig M, Woods W, Evans J, Rouhana SW, Higuchi K, Tanji H, St Lawrence S, Arbogast KB: Biomechanical response of the pediatric abdomen, Part 2: injuries and their correlation with engineering parameters. Stapp Car Crash J; 2008 Nov;52:135-66
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Biomechanical response of the pediatric abdomen, Part 2: injuries and their correlation with engineering parameters.
  • This paper describes the injuries generated during dynamic belt loading to a porcine model of the 6-year-old human abdomen, and correlates injury outcomes with measurable parameters.
  • The test fixture produced transverse, dynamic belt loading on the abdomen of 47 immediately post-mortem juvenile swine at two locations (upper/lower), with penetration magnitudes ranging from 23% - 65% of the undeformed abdominal depth, with and without muscle tensing, and over a belt penetration rate range of 2.9 m/s - 7.8 m/s.
  • The injury distribution matched well the pattern of injuries observed in a large sample of children exposed to seatbelt loading in the field, with most of the injuries in the lower abdomen.
  • Univariate and multiple regression models were used to assess mechanical predictors as injury criteria for maximum AIS 2+ and 3+ outcomes, including peak belt tension and posterior reaction force, abdominal penetration, penetration rate, the viscous criterion, and a newly proposed criterion, FCmax, which is the maximum of the instantaneous product of loading rate and normalized penetration.
  • The best discriminators were peak belt tension (gamma = 0.86 and 0.83, p < 0.01), the work done by the deforming thorax (gamma = 0.86 and 0.74, p < 0.01), and abdominal penetration (gamma = 0.89 and 0.66, p < 0.02).
  • [MeSH-major] Abdomen / physiology. Abdominal Injuries. Seat Belts / adverse effects

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19085161.001).
  • [ISSN] 1532-8546
  • [Journal-full-title] Stapp car crash journal
  • [ISO-abbreviation] Stapp Car Crash J
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


8. Androutsopoulos G, Adonakis G, Ravazoula P, Kourounis G: Vaginal cancer in a patient treated for cervical intraepithelial neoplasia (CIN 3): case report. Eur J Gynaecol Oncol; 2006;27(6):638-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vaginal cancer in a patient treated for cervical intraepithelial neoplasia (CIN 3): case report.
  • In 1% to 3% of patients with cervical intraepithelial neoplasia (CIN), vaginal intraepithelial neoplasia (VAIN) will either coexist or occur at a later date.
  • The time interval from an earlier diagnosis of CIN 3 to a current diagnosis of VAIN 3 varies from two to 17 years.
  • Invasive vaginal cancer occurred in a woman five years after total abdominal hysterectomy for cervical intraepithelial neoplasia.
  • In women who have undergone total hysterectomy for cervical intraepithelial neoplasia or cervical cancer, postoperative cytologic and colposcopic follow-up of the vagina is necessary.
  • [MeSH-major] Carcinoma in Situ / pathology. Cervical Intraepithelial Neoplasia / pathology. Neoplasms, Squamous Cell / pathology. Uterine Cervical Neoplasms / pathology. Vaginal Neoplasms / pathology


9. Abe K, Shiozawa N, Makikawa M: Hyperthermia system with thermoseed set in abdominal cavity and AC-magnetic-field. Conf Proc IEEE Eng Med Biol Soc; 2007;2007:1483-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hyperthermia system with thermoseed set in abdominal cavity and AC-magnetic-field.
  • We propose a hyperthermia system for cancer developed in abdominal cavity.
  • [MeSH-major] Abdominal Cavity / physiology. Computer-Aided Design. Electromagnetic Phenomena / instrumentation. Hyperthermia, Induced / instrumentation. Models, Biological. Prostheses and Implants

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18002247.001).
  • [ISSN] 1557-170X
  • [Journal-full-title] Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference
  • [ISO-abbreviation] Conf Proc IEEE Eng Med Biol Soc
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


10. Giles JR, Elkin RG, Trevino LS, Urick ME, Ramachandran R, Johnson PA: The restricted ovulator chicken: a unique animal model for investigating the etiology of ovarian cancer. Int J Gynecol Cancer; 2010 Jul;20(5):738-44
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The restricted ovulator chicken: a unique animal model for investigating the etiology of ovarian cancer.
  • OBJECTIVE: The main goal of this study was to compare the incidence of ovarian cancer (OC) in 2 genetically different lines of hens--one that generally fails to lay eggs (the mutant "restricted ovulator" [RO] strain) and the other consisting of the wild-type (WT) siblings of the mutant RO hens.
  • At 38 months of age, hens were killed, and their abdominal cavities were examined for any gross evidence of tumors.


11. Alonso Moralejo R, Sayas Catalán J, García Luján R, Coronado Poggio M, Monsó Molas E, López Encuentra A: [Use of positron emission tomography in assessing hidden extrathoracic metastasis in non small cell lung cancer]. Arch Bronconeumol; 2010 May;46(5):238-43
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Use of positron emission tomography in assessing hidden extrathoracic metastasis in non small cell lung cancer].
  • [Transliterated title] Utilidad de la tomografía por emisión de positrones en la detección de metástasis ocultas extratorácicas en el carcinoma broncogénico no células pequeñas.
  • INTRODUCTION: Positron emission tomography combined with computed axial tomography (PET/CT) is used for staging non small cell lung cancer (NSCLC).
  • PATIENTS AND METHOD: Prospective and concurrent study including all NSCLC patients between June 2004 and November 2006 who underwent PET/CT after considering them as candidates for surgery, with resectable disease after bronchoscopy, thorax and abdominal CT, brain CT and bone gammagraphy evaluation, if metastasis at these locations were suspected.
  • In 3 of these cases (13.1%) extrathoracic uptakes corresponded to metacrhonous tumours or pre-malignant conditions.
  • CONCLUSIONS: PET/CT is a complementary diagnosis method for assessing hidden metastases which could modify the therapeutical approach in patients otherwise suitable for surgery.
  • [MeSH-major] Carcinoma, Non-Small-Cell Lung / diagnosis. Carcinoma, Non-Small-Cell Lung / secondary. Lung Neoplasms / pathology. Positron-Emission Tomography. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Lung Cancer.
  • Genetic Alliance. consumer health - Non-small cell lung cancer.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 SEPAR. Published by Elsevier Espana. All rights reserved.
  • (PMID = 20378233.001).
  • [ISSN] 1579-2129
  • [Journal-full-title] Archivos de bronconeumología
  • [ISO-abbreviation] Arch. Bronconeumol.
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Spain
  •  go-up   go-down


12. Lowe MP, Kumar S, Johnson PR, Kamelle SA, Chamberlain DH, Tillmanns TD: Robotic surgical management of endometrial cancer in octogenarians and nonagenarians: analysis of perioperative outcomes and review of the literature. J Robot Surg; 2010 Aug;4(2):109-15
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Robotic surgical management of endometrial cancer in octogenarians and nonagenarians: analysis of perioperative outcomes and review of the literature.
  • The primary aim of this article is to report the outcomes of octogenarians and nonagenarians who have undergone robotic surgery for endometrial cancer.
  • A multi-institutional research consortium was created to evaluate the utility of robotics for gynecologic surgery (benign and malignant).
  • A multi-institutional HIPPA compliant database was then created and analyzed for all patients that underwent robotic-assisted surgery with staging for endometrial cancer between the April 2003 and January 2009.
  • Over one-half (56%) of the patients reported a prior abdominal surgery.
  • We conclude that robotic surgery is safe, feasible, and expands surgical options for octogenarians and nonagenarians diagnosed with endometrial cancer.
  • Age should not be considered a contraindication for robotic surgical management of patients with endometrial cancer.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Med Robot. 2009 Dec;5(4):392-7 [19455550.001]
  • [Cites] Cancer. 1994 Oct 1;74(7 Suppl):2208-14 [8087794.001]
  • [Cites] Obstet Gynecol. 2008 Dec;112(6):1207-13 [19037027.001]
  • [Cites] Gynecol Oncol. 2007 Sep;106(3):572-8 [17618678.001]
  • [Cites] J Clin Oncol. 2009 Nov 10;27(32):5331-6 [19805679.001]
  • [Cites] Obstet Gynecol. 2009 Aug;114(2 Pt 1):236-43 [19622983.001]
  • [Cites] Gynecol Oncol. 2006 Jun;101(3):470-5 [16413048.001]
  • [Cites] N Engl J Med. 1999 Dec 30;341(27):2061-7 [10615079.001]
  • [Cites] Gynecol Oncol. 2005 Feb;96(2):362-7 [15661222.001]
  • [Cites] Am J Obstet Gynecol. 2008 Jun;198(6):679.e1-9; discussion 679.e9-10 [18538151.001]
  • [Cites] Gynecol Oncol. 2009 Aug;114(2):168-72 [19446869.001]
  • [Cites] Gynecol Oncol. 2008 Dec;111(3):412-7 [18834620.001]
  • [Cites] Curr Opin Obstet Gynecol. 2005 Aug;17(4):343-6 [15976538.001]
  • [Cites] Am J Obstet Gynecol. 2008 Oct;199(4):360.e1-9 [18928974.001]
  • [Cites] J Clin Oncol. 2003 Apr 15;21(8):1618-23 [12697888.001]
  • [Cites] Gynecol Oncol. 2001 Dec;83(3):563-8 [11733973.001]
  • (PMID = 27628776.001).
  • [ISSN] 1863-2483
  • [Journal-full-title] Journal of robotic surgery
  • [ISO-abbreviation] J Robot Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Elderly / Endometrial cancer / Minimally invasive surgery / Octogenarians / Robotic hysterectomy / Robotic surgery / Uterine cancer
  •  go-up   go-down


13. Bruzzone A, Varaldo M, Ferrarazzo C, Tunesi G, Mencoboni M: Solitary fibrous tumor. Rare Tumors; 2010;2(4):e64
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Solitary fibrous tumor.
  • Solitary fibrous tumor (SFT) is a rare mesenchymal neoplasm which may be found everywhere in the body.
  • Abdominal localizations are quite rare, with 10 cases only reported in bladder; rarely they can be source of paraneoplastic syndromes (i.e., hypoglycemia secondary to insulin-like growth factor).
  • In April 2006 a 74-year-old white male presented with chills, diaphoresis and acute abdominal pain with hematuria.
  • At admission in emergency he underwent an abdominal Xray (no pathological findings) and an ultrasound examination of the kidneys and urinary tract, which revealed a pelvic hyperechogenic neoformation measuring approximately 10×8×7 cm, compressing the bladder.
  • Contrast enhanced CT scan of the abdomen and pelvic region revealed a large round neoformation dislocating the bladder, with an evident contrast-enhanced periphery and a central necrotic area.
  • The patient underwent complete surgical resection of an ovoidal mass coated by adipose tissue, with well delimited margins; histological findings were consistent with solitary fibrous tumor (SFT).

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hum Pathol. 1999 Dec;30(12):1464-73 [10667425.001]
  • [Cites] Exp Clin Endocrinol Diabetes. 2000;108(8):515-8 [11149628.001]
  • [Cites] Virchows Arch. 2002 Mar;440(3):249-60 [11889594.001]
  • [Cites] Cancer. 2002 Feb 15;94(4):1057-68 [11920476.001]
  • [Cites] Ann Oncol. 2004 Nov;15(11):1667-72 [15520069.001]
  • [Cites] Int J Clin Oncol. 2006 Dec;11(6):478-81 [17180519.001]
  • [Cites] Lung Cancer. 2009 May;64(2):244-6 [19041155.001]
  • [Cites] Hum Pathol. 1995 Apr;26(4):440-9 [7705824.001]
  • [Cites] World J Surg Oncol. 2008;6:16 [18254983.001]
  • [Cites] Cancer Genet Cytogenet. 2008 Feb;181(1):60-4 [18262056.001]
  • [Cites] Korean J Radiol. 2008 Jul;9 Suppl:S48-51 [18607126.001]
  • [Cites] J Thorac Oncol. 2008 Aug;3(8):938-41 [18670317.001]
  • [Cites] Am J Surg Pathol. 2008 Nov;32(11):1627-42 [18753943.001]
  • (PMID = 21234256.001).
  • [ISSN] 2036-3613
  • [Journal-full-title] Rare tumors
  • [ISO-abbreviation] Rare Tumors
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  • [Other-IDs] NLM/ PMC3019599
  • [Keywords] NOTNLM ; rare tumors. / solitary fibrous tumor
  •  go-up   go-down


14. Dutta S, Wang FQ, Phalen A, Fishman DA: Biomarkers for ovarian cancer detection and therapy. Cancer Biol Ther; 2010 May 1;9(9):668-77
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Biomarkers for ovarian cancer detection and therapy.
  • Despite advances in surgical technologies and the development of more effective chemotherapeutics, epithelial ovarian cancer (EOC) remains the leading cause of death in women with gynecologic malignancies.
  • The high mortality and morbidity associated with EOC is mostly attributed to the inability to detect the disease before it is widely disseminated throughout the abdominal cavity.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Biomarkers, Tumor / metabolism. Ovarian Neoplasms / metabolism

  • Genetic Alliance. consumer health - Ovarian cancer.
  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20372062.001).
  • [ISSN] 1555-8576
  • [Journal-full-title] Cancer biology & therapy
  • [ISO-abbreviation] Cancer Biol. Ther.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R21 CA125227-01; United States / Howard Hughes Medical Institute / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Biomarkers, Tumor
  •  go-up   go-down


15. Rodríguez GF, Vasco PG, Callejas ME, Revilla FJ: Retroperitoneal leiomyomata as a cause of bilateral hydronephrosis and lumbosciatic pain. BMJ Case Rep; 2009;2009
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Leiomyomas can occasionally be found in the pelvic and/or abdominal parietal retroperitoneum.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22162734.001).
  • [ISSN] 1757-790X
  • [Journal-full-title] BMJ case reports
  • [ISO-abbreviation] BMJ Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC3028425
  •  go-up   go-down


16. Bouchahda M, Adam R, Giacchetti S, Castaing D, Brezault-Bonnet C, Hauteville D, Innominato PF, Focan C, Machover D, Lévi F: Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancer. Cancer; 2009 Nov 1;115(21):4990-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancer.
  • In this article, the authors report their experience with chronomodulated HAI chemotherapy as rescue therapy in heavily pretreated patients who had metastatic colorectal cancer.
  • METHODS: : Data from all consecutive patients with colorectal cancer liver metastases who received HAI with chronomodulated, multidrug chemotherapy regimens in the authors' center after failure on standard chemotherapy were reviewed for efficacy and safety.
  • The most frequent grade (according to National Cancer Institute of Canada Common Toxicity Criteria [version 3]) 3 and 4 nonhematologic toxicities were vomiting, diarrhea, abdominal pain, and fatigue.
  • An objective tumor response was observed in 10 patients (34.5%), including 4 patients who subsequently underwent R0 or R1 hepatic resection.
  • Cancer 2009. (c) 2009 American Cancer Society.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / administration & dosage. Chemotherapy, Cancer, Regional Perfusion. Colorectal Neoplasms / drug therapy. Infusions, Intra-Arterial. Liver Neoplasms / drug therapy


17. Yin J, Zhang T, Zhang XH, Li HX, Xiao CH, Cao XC, Zhang TH: [Research on the postoperative complications and its risk factors of breast reconstruction with abdominal flaps]. Zhonghua Wai Ke Za Zhi; 2009 Dec 15;47(24):1864-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Research on the postoperative complications and its risk factors of breast reconstruction with abdominal flaps].
  • OBJECTIVE: To study the postoperative complications and its risk factors in patients underwent breast reconstruction with abdominal flaps.
  • METHODS: The clinical data of 115 cases underwent breast reconstructions with abdominal flaps from May 2001 to October 2008 was reviewed.
  • The donor-site complications included fat liquefaction which occurred in 8 cases (7.0%) and infection in 3 cases (2.6%).
  • Abdominal flap should be performed with more consideration in active smokers or patients with a radiotherapy history.
  • Age and obesity should not be contraindications to breast reconstruction with abdominal flaps.
  • [MeSH-minor] Abdomen / surgery. Adult. Breast Neoplasms / surgery. Female. Humans. Middle Aged. Retrospective Studies. Risk Factors

  • MedlinePlus Health Information. consumer health - After Surgery.
  • MedlinePlus Health Information. consumer health - Breast Reconstruction.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20193403.001).
  • [ISSN] 0529-5815
  • [Journal-full-title] Zhonghua wai ke za zhi [Chinese journal of surgery]
  • [ISO-abbreviation] Zhonghua Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


18. Nagahama T, Ando M, Ami K, Ohbu M: [Weekly docetaxel in combination with concomitant radiotherapy for esophageal cancer]. Gan To Kagaku Ryoho; 2005 Oct;32(11):1733-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Weekly docetaxel in combination with concomitant radiotherapy for esophageal cancer].
  • Docetaxel (DOC) has demonstrated an activity as a radiation sensitizer in head and neck cancer.
  • We have experienced four cases of esophageal cancer treated by weekly DOC in combination with concomitant radiotherapy.
  • Three cases of advanced esophageal cancer and a case of relapsed esophageal cancer after administration of 5-FU and CDDP were enrolled in this pilot trial.
  • One case showed a complete response developed abdominal para aortic lymph node and liver recurrence 12 months after the treatment.
  • A weekly administration of low dose DOC in combination with radiotherapy was very effective for advanced esophageal cancer.

  • Genetic Alliance. consumer health - Esophageal Cancer.
  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • Hazardous Substances Data Bank. DOCETAXEL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16315924.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Phytogenic; 0 / Radiation-Sensitizing Agents; 0 / Taxoids; 15H5577CQD / docetaxel
  •  go-up   go-down


19. Shimobayashi T, Inatsugi N, Yoshikawa S, Masuda T, Uchida H, Kuge H, Yokotani T, Yamaguchi T, Kawaguchi C, Yamaoka K, Inagaki M, Matsuoka M, Tatsumi K, Saraya T, Otsuji T, Yamochi Y, Yamanishi K, Enomoto Y, Nonomura A, Sho M, Nakajima Y: [A surgical (right lobectomy) case of liver metastasis of colon cancer after chemotherapy using mFOLFIRI and cetuximab]. Gan To Kagaku Ryoho; 2010 Nov;37(12):2340-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A surgical (right lobectomy) case of liver metastasis of colon cancer after chemotherapy using mFOLFIRI and cetuximab].
  • A man in his early seventies underwent low anterior resection and partial resection of the liver for the rectal cancer and liver metastasis.
  • However, 4 months after the surgery, he was found to have a liver tumor at S5 and S7 by abdominal CT scan.
  • Then, he underwent chemotherapy (mFOLFOX6), but the metastatic tumor was progressive.
  • We selected FOLFIRI + cetuximab regimen for second-line therapy to resect the metastatic tumor.
  • We conducted a right lobectomy of the liver, and the tumor was completely resected.

  • Genetic Alliance. consumer health - Liver cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • Hazardous Substances Data Bank. CETUXIMAB .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • Hazardous Substances Data Bank. LEUCOVORIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21224566.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Humanized; 0 / Antineoplastic Agents; PQX0D8J21J / Cetuximab; Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil; XT3Z54Z28A / Camptothecin; IFL protocol
  •  go-up   go-down


20. Ivatury RR: Update on open abdomen management: achievements and challenges. World J Surg; 2009 Jun;33(6):1150-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Update on open abdomen management: achievements and challenges.
  • The open abdomen technique is one of the greatest advances in recent times and has enormous application in the daily management of the critically ill or injured patient.
  • Recent advances in the management of the open abdomen have provided the means to overcome the challenges and reap the benefits.
  • [MeSH-major] Abdominal Wall / surgery. Compartment Syndromes / prevention & control. Critical Illness. Decompression, Surgical / methods. Postoperative Complications / prevention & control

  • MedlinePlus Health Information. consumer health - After Surgery.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] JPEN J Parenter Enteral Nutr. 2007 Sep-Oct;31(5):410-5 [17712150.001]
  • [Cites] Intensive Care Med. 2006 Nov;32(11):1912-4 [16896853.001]
  • [Cites] J Am Coll Surg. 2008 Oct;207(4):573-9 [18926462.001]
  • [Cites] Br J Surg. 1996 Jan;83(1):112 [8653331.001]
  • [Cites] J Trauma. 1998 Jun;44(6):1016-21; discussion 1021-3 [9637157.001]
  • [Cites] J Am Coll Surg. 2006 Sep;203(3):390-6 [16931311.001]
  • [Cites] Am J Surg. 2002 Aug;184(2):166-7 [12169362.001]
  • [Cites] Am Surg. 2008 Oct;74(10):891-7 [18942608.001]
  • [Cites] World J Surg. 2009 Feb;33(2):199-207 [19089494.001]
  • [Cites] Surgery. 2006 Oct;140(4):570-6; discussion 576-8 [17011904.001]
  • [Cites] Crit Care Med. 2007 Jan;35(1):127-31 [17095940.001]
  • [Cites] J Trauma. 2002 Dec;53(6):1121-8 [12478038.001]
  • [Cites] Ann Plast Surg. 2006 Dec;57(6):621-5 [17122546.001]
  • [Cites] Surg Clin North Am. 1997 Aug;77(4):783-800 [9291981.001]
  • [Cites] Surg Infect (Larchmt). 2006 Oct;7(5):433-41 [17083309.001]
  • [Cites] J Am Coll Surg. 2008 Nov;207(5):690-7 [18954781.001]
  • [Cites] J Trauma. 2002 Apr;52(4):625-31; discussion 632 [11956374.001]
  • [Cites] J Trauma. 2008 Aug;65(2):337-42; discussion 342-4 [18695468.001]
  • [Cites] Am J Surg. 2001 Dec;182(6):542-6 [11839314.001]
  • (PMID = 19350323.001).
  • [ISSN] 1432-2323
  • [Journal-full-title] World journal of surgery
  • [ISO-abbreviation] World J Surg
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 20
  •  go-up   go-down


21. Hazarika N, Dhabhar B, Saikia TK: Highly elevated serum CA 125 in a lady with ascites and retroperitoneal mass--a diagnostic dilemma. J Assoc Physicians India; 2008 Jan;56:47-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Cancer antigen 125 (CA 125), a widely used tumor marker for monitoring epithelial ovarian cancer, is also found to be raised in non-gynecological tumors and non malignant disease involving peritoneum.
  • CONCLUSION: In a female patient with ascitis with high serum CA 125 level, a differential diagnosis of lymphoma should not be overlooked unless cytology comes positive for epithelial carcinoma cells.
  • [MeSH-major] Ascites / etiology. CA-125 Antigen. Lymphoma, Large B-Cell, Diffuse / diagnosis. Retroperitoneal Neoplasms / diagnosis
  • [MeSH-minor] Antimetabolites, Antineoplastic / administration & dosage. Antimetabolites, Antineoplastic / therapeutic use. Antineoplastic Agents, Phytogenic / administration & dosage. Antineoplastic Agents, Phytogenic / therapeutic use. Antineoplastic Combined Chemotherapy Protocols / administration & dosage. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Cyclophosphamide / administration & dosage. Cyclophosphamide / therapeutic use. Deoxycytidine / administration & dosage. Deoxycytidine / analogs & derivatives. Deoxycytidine / therapeutic use. Doxorubicin / administration & dosage. Doxorubicin / therapeutic use. Female. Humans. Middle Aged. Paclitaxel / administration & dosage. Paclitaxel / therapeutic use. Prednisone / administration & dosage. Prednisone / therapeutic use. Radiography, Abdominal. Tomography, X-Ray Computed. Treatment Outcome. Vincristine / administration & dosage. Vincristine / therapeutic use

  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. TAXOL .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. PREDNISONE .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18472501.001).
  • [ISSN] 0004-5772
  • [Journal-full-title] The Journal of the Association of Physicians of India
  • [ISO-abbreviation] J Assoc Physicians India
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0 / Antineoplastic Agents, Phytogenic; 0 / CA-125 Antigen; 0W860991D6 / Deoxycytidine; 5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; B76N6SBZ8R / gemcitabine; P88XT4IS4D / Paclitaxel; VB0R961HZT / Prednisone; CHOP protocol
  •  go-up   go-down


22. Fritz TR, Swischuk LE: Macrodystrophia lipomatosa extending into the upper abdomen. Pediatr Radiol; 2007 Dec;37(12):1275-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Macrodystrophia lipomatosa extending into the upper abdomen.
  • We report a case of macrodystrophia lipomatosa in an infant with extension of hypertrophied fatty tissue into the abdomen and abdominal wall.
  • The patient not only presented with typical limb abnormalities but also an abdominal mass.
  • We reviewed the literature on the subject, and believe that our case is rare because the hypertrophied lipomatous tissue extended into the abdomen.
  • [MeSH-major] Abdomen / pathology. Foot Deformities, Congenital / pathology. Leg / abnormalities. Lipomatosis / pathology
  • [MeSH-minor] Female. Humans. Infant, Newborn. Magnetic Resonance Imaging. Radiography, Abdominal

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Bone Joint Surg Am. 2007 May;89(5):1097-102 [17473149.001]
  • [Cites] Clin Imaging. 1997 Mar-Apr;21(2):135-7 [9095390.001]
  • [Cites] Acta Radiol. 1992 Nov;33(6):554-5 [1333257.001]
  • [Cites] AJR Am J Roentgenol. 1992 Jun;158(6):1295-7 [1590127.001]
  • [Cites] J Bone Joint Surg Br. 1969 May;51(2):348-53 [5770417.001]
  • [Cites] Am J Med Genet A. 2003 May 15;119A(1):63-5 [12707961.001]
  • [Cites] AJR Am J Roentgenol. 1977 Jan;128(1):101-5 [401563.001]
  • (PMID = 17879091.001).
  • [ISSN] 0301-0449
  • [Journal-full-title] Pediatric radiology
  • [ISO-abbreviation] Pediatr Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 8
  •  go-up   go-down


23. Eisenkop SM: Total laparoscopic hysterectomy with pelvic/aortic lymph node dissection for endometrial cancer--a consecutive series without case selection and comparison to laparotomy. Gynecol Oncol; 2010 May;117(2):216-23
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Total laparoscopic hysterectomy with pelvic/aortic lymph node dissection for endometrial cancer--a consecutive series without case selection and comparison to laparotomy.
  • OBJECTIVE: To determine feasibility of duplicating operative time and nodal yield of "open" procedures by using laparoscopy for clinically localized endometrial cancer without case selection and eliminating influence of BMI on conversion.
  • There was no influence of BMI (P=0.688), age (P=0.748) or the number of prior abdominal operations (P=0.875) on probability of conversion (Logistic regression).
  • The mean age, BMI, number of prior abdominal procedures, and GOG performance status were equivalent in both study groups.
  • CONCLUSIONS: For clinically localized endometrial cancer, TLH/BSO/LND can functionally duplicate operative time equivalent to "open" procedures, while improving nodal yield, and minimizing influence of BMI on conversion to laparotomy and case selection.

  • Genetic Alliance. consumer health - Endometrial cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010. Published by Elsevier Inc.
  • (PMID = 20138346.001).
  • [ISSN] 1095-6859
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


24. Jeremić K, Petković S, Stefanović A, Gojnić M, Maksimović M, Stojnić J, Likić I, Kadija S, Atanacković J: [Radical treachelectomy in treatment of early stages of cervical cancer]. Acta Chir Iugosl; 2008;55(4):93-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Radical treachelectomy in treatment of early stages of cervical cancer].
  • The aim of the study was to determine if radical trachelectomy with pelvic lymphonodectomy could be a method for treatment of early cervical cancer to preserve fertility.
  • Diagnostic method for cervical cancer was histologic examination, cone or biopsy.
  • We performed abdominal radical trachelectomy with pelvic lymphonodectomy.
  • In two-year follow-up period we did not find any sign of residual cancer.
  • We concluded that radical trachelectomy with pelvic lymphonodectomy could be appropriate method for treatment of early stage cervical cancer.

  • Genetic Alliance. consumer health - Cervical cancer.
  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19245148.001).
  • [ISSN] 0354-950X
  • [Journal-full-title] Acta chirurgica Iugoslavica
  • [ISO-abbreviation] Acta Chir Iugosl
  • [Language] srp
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Serbia
  •  go-up   go-down


25. Funaki H, Ohnishi T, Ohno Y, Tomita Y, Hosokawa K, Yokoi M, Yoshitani S, Kinami S, Omote K, Ueda N, Nakano Y, Kosaka T: [A case of AGC with pCR after preoperative chemotherapy including S-1 plus cisplatin]. Gan To Kagaku Ryoho; 2010 Nov;37(12):2430-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 79-year-old man complaining of epigastralgia was examined and diagnosed with advanced gastric cancer (UML, Type 5, Ant-Less-Gre, cT4a, cN1, cH0, cP1, cStage IV).
  • A poor prognosis was predicted, but we tried preoperative chemotherapy hoping for a down-staging of the tumor.
  • After three cycles of treatment, diagnostic laparoscopic examination revealed a suspected serosal invasion of the main tumor, but peritoneal dissemination was not seen, and abdominal washing cytology was negative.
  • Histological examination of the resected specimens revealed no residual cancer cells in the primary lesion or regional lymph nodes, resulting in a diagnosis of complete response to chemotherapy according to the Japanese Classification of Gastric Carcinoma.

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21224596.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0 / Antineoplastic Agents; 0 / Drug Combinations; 150863-82-4 / S 1 (combination); 1548R74NSZ / Tegafur; 5VT6420TIG / Oxonic Acid; Q20Q21Q62J / Cisplatin
  •  go-up   go-down


26. Bakhos C, Alazemi S, Michaud G, DeCamp MM: Staged repair of benign tracheo-neo-esophageal fistula 12 years after esophagectomy for esophageal cancer. Ann Thorac Surg; 2010 Dec;90(6):e83-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Staged repair of benign tracheo-neo-esophageal fistula 12 years after esophagectomy for esophageal cancer.
  • Benign tracheo-neo-esophageal fistula is a rare complication after esophagectomy.
  • He finally underwent Roux-en-Y gastro-jejunostomy through a left thoraco-abdominal approach to restore the gastrointestinal continuity.

  • Genetic Alliance. consumer health - Esophageal Cancer.
  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
  • [CommentIn] Ann Thorac Surg. 2012 Oct;94(4):1375; author reply 1375-6 [22487402.001]
  • (PMID = 21095291.001).
  • [ISSN] 1552-6259
  • [Journal-full-title] The Annals of thoracic surgery
  • [ISO-abbreviation] Ann. Thorac. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


27. Tamura K, Tani M, Kinoshita H, Yamaue H: Mesenteric desmoid tumor of the interposed jejunal pouch after total gastrectomy. World J Surg Oncol; 2006;4:27
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mesenteric desmoid tumor of the interposed jejunal pouch after total gastrectomy.
  • BACKGROUND: Desmoid tumor is a rare entity, and most desmoid tumors are located in abdominal wall or extra-abdominal tissues.
  • Occurrence of desmoid tumor in mesentry is extremely rare.
  • CASE PRESENTATION: we report a mesenteric desmoid tumor in a 73-years-old woman who had undergone total gastrectomy reconstructed with jejunal pouch interposition for gastric carcinoma.
  • After 1 year, a tumor was originating from mesentery of the interposed jejunal pouch was identified, and the patient underwent resection of the large mass which was found to invade pancreas.
  • Histological examination revealed desmoid tumor.
  • CONCLUSION: Desmoid tumor is rare, and it was difficult for the differential diagnosis of desmoid tumor or recurrent tumor.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Oncol. 1999 Jan;17(1):158-67 [10458229.001]
  • [Cites] Gut. 2001 Apr;48(4):515-21 [11247896.001]
  • [Cites] Cancer. 2004 Feb 1;100(3):612-20 [14745880.001]
  • [Cites] Arch Surg. 1979 Oct;114(10):1181-5 [158353.001]
  • [Cites] J Clin Oncol. 2006 Jan 1;24(1):11-2 [16330666.001]
  • [Cites] Br J Surg. 1996 Nov;83(11):1494-504 [9014661.001]
  • [Cites] Arch Surg. 1991 Dec;126(12):1469-73 [1842175.001]
  • [Cites] Ann Surg. 1989 Dec;210(6):765-9 [2531573.001]
  • [Cites] Eur J Cancer Clin Oncol. 1986 May;22(5):583-7 [3770030.001]
  • [Cites] Am J Clin Pathol. 1982 Jun;77(6):665-73 [7091046.001]
  • [Cites] Cancer. 1994 Aug 15;74(4):1270-4 [7519966.001]
  • [Cites] World J Surg Oncol. 2006;4:21 [16584569.001]
  • (PMID = 16740152.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1481628
  •  go-up   go-down


28. Yajima K, Kobayashi T, Ohashi M, Kurosaki R, Kurosaki I, Matsuo H, Hatakeyama K: [Complete resection of advanced gastric cancer with multiple liver metastases following a bypass operation and one year of chemotherapy]. Gan To Kagaku Ryoho; 2007 Aug;34(8):1283-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Complete resection of advanced gastric cancer with multiple liver metastases following a bypass operation and one year of chemotherapy].
  • We report a case of advanced gastric cancer with multiple liver metastases,in which a complete resection was performed following a bypass operation and chemotherapy.
  • Gastrointestinal endoscopy revealed advanced gastric cancer with pyloric stenosis, and abdominal computed tomography showed multiple liver metastases in segments 2, 3, 5, and 6.
  • The primary tumor and liver tumors remained stable following the 3 cycles of S-1 plus cisplatin, but the liver tumors were considerably smaller after 3 cycles of wPTX.
  • The patient received 6 cycles of wPTX as adjuvant therapy,and remained well with no evidence of tumor recurrence 28 months after the initial treatment.

  • Genetic Alliance. consumer health - Liver cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. TAXOL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17687214.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Drug Combinations; 150863-82-4 / S 1 (combination); 1548R74NSZ / Tegafur; 5VT6420TIG / Oxonic Acid; P88XT4IS4D / Paclitaxel; Q20Q21Q62J / Cisplatin
  •  go-up   go-down


29. Vega SJ, Sandeen SN, Bossert RP, Perrone A, Ortiz L, Herrera H: Gracilis myocutaneous free flap in autologous breast reconstruction. Plast Reconstr Surg; 2009 Nov;124(5):1400-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It avoids abdominal donor-site morbidity, allows for a quicker recovery, provides an alternative to the thin patient with a hidden and acceptable donor site, and allows for supine positioning for harvest and inset in a timely fashion.
  • CONCLUSIONS: The gracilis myocutaneous free flap provides an alternative breast reconstruction option for today's breast cancer patient.
  • It allows for a quick harvest in the supine setting, creation of a moderate breast volume, consistent anatomy, and acceptable donor-site morbidity with good contour.

  • MedlinePlus Health Information. consumer health - Breast Reconstruction.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20009824.001).
  • [ISSN] 1529-4242
  • [Journal-full-title] Plastic and reconstructive surgery
  • [ISO-abbreviation] Plast. Reconstr. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


30. Osawa A, Sumiyama Y, Watanabe M, Tanaka H, Asai K, Enomoto T, Matsukiyo H, Kanai R, Takeuchi Y, Oharazeki T: Single case of renal cell carcinoma and endocrine pancreatic head cancer occurring with von Hippel-Lindau disease. J Hepatobiliary Pancreat Surg; 2006;13(2):174-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Single case of renal cell carcinoma and endocrine pancreatic head cancer occurring with von Hippel-Lindau disease.
  • Reported here is a case of VHL disease with concurrent renal cell carcinoma and endocrine pancreatic cancer.
  • Abdominal ultrasound and computed tomography scans revealed a mass in the right kidney and a mass in the pancreatic head.
  • After various tests were performed, the patient was diagnosed with right renal cell carcinoma, malignant tumor of the pancreatic head, and multiple pancreatic cysts accompanying von Hippel-Lindau disease.
  • Based on the histopathological results, the patient was diagnosed with right renal cell carcinoma and highly differentiated endocrine pancreatic cancer.
  • Immunohistologically, a large number of atypical cells were found to be positive for both anti-chromogranin and anti-synaptophysin antibodies in the endocrine tumor.
  • Based on the above findings, nonfunctioning, highly differentiating endocrine cancer was diagnosed.
  • This is the first confirmed case of renal cell carcinoma and endocrine pancreatic cancer occurring concurrently with VHL.
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Tomography, X-Ray Computed


31. Zhan YQ, Li W, Sun XW, Chen YB, Xu L, Chen G, Guan YX, Li YF, Xu DZ, Sun XF, Zhang HZ, Lin ZW: [Long-term results of surgical treatment of stomach cancer: clinical experience of forty years from Sun Yat-sen University Cancer Center]. Zhonghua Wai Ke Za Zhi; 2005 Sep 1;43(17):1109-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Long-term results of surgical treatment of stomach cancer: clinical experience of forty years from Sun Yat-sen University Cancer Center].
  • OBJECTIVE: To investigate the approaches to improve therapeutic effect of stomach cancer by analysis of the long-term results of surgical treatment of this disease.
  • METHODS: Prognostic factors of stomach cancer were analyzed by Cox multivariate regression model based on clinical data of 2561 stomach cancer cases who underwent surgical treatment from 1964 to 2004 at Sun Yat-sen University Cancer Center.
  • Multivariate analysis indicated that main prognostic factors of stomach cancer included TNM staging, curative resection and multidisciplinary treatment.
  • CONCLUSIONS: Early detection and curative resection were the most important measures to improve therapeutic effect of stomach cancer.
  • A surgery-predominant multidisciplinary treatment individualizing biological characteristics of tumor, staging of disease and tumor site will contribute to improvement of therapeutic effect of stomach cancer.

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16194306.001).
  • [ISSN] 0529-5815
  • [Journal-full-title] Zhonghua wai ke za zhi [Chinese journal of surgery]
  • [ISO-abbreviation] Zhonghua Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


32. Nisticò C, Bria E, Cuppone F, Carpino A, Ferretti G, Vitelli G, Sperduti I, Calabretta F, Toglia G, Tomao S, Cognetti F, Terzoli E: Troponin-T and myoglobin plus echocardiographic evaluation for monitoring early cardiotoxicity of weekly epirubicin-paclitaxel in metastatic breast cancer patients. Anticancer Drugs; 2007 Feb;18(2):227-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Troponin-T and myoglobin plus echocardiographic evaluation for monitoring early cardiotoxicity of weekly epirubicin-paclitaxel in metastatic breast cancer patients.
  • From January 2002, 20 patients with untreated advanced breast cancer received epirubicin (25 mg/m/week) and paclitaxel (80 mg/m/week) for 24 weeks.
  • Myoglobin never significantly increased with the exception of a patient who underwent several abdominal fluid drainages.

  • Genetic Alliance. consumer health - Breast Cancer.
  • Genetic Alliance. consumer health - Metastatic cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • Hazardous Substances Data Bank. TAXOL .
  • Hazardous Substances Data Bank. EPIRUBICIN .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17159609.001).
  • [ISSN] 0959-4973
  • [Journal-full-title] Anti-cancer drugs
  • [ISO-abbreviation] Anticancer Drugs
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase II; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antibiotics, Antineoplastic; 0 / Antineoplastic Agents, Phytogenic; 0 / Myoglobin; 0 / Troponin T; 3Z8479ZZ5X / Epirubicin; P88XT4IS4D / Paclitaxel
  •  go-up   go-down


33. Borschitz T, Heintz A, Junginger T: Transanal endoscopic microsurgical excision of pT2 rectal cancer: results and possible indications. Dis Colon Rectum; 2007 Mar;50(3):292-301
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transanal endoscopic microsurgical excision of pT2 rectal cancer: results and possible indications.
  • PURPOSE: In previous studies, local excision was predominantly established for "low-risk" pT1 rectal cancer.
  • [MeSH-minor] Aged. Aged, 80 and over. Anal Canal. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local. Proctoscopy. Prognosis. Reoperation. Risk Factors. Treatment Outcome

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17252286.001).
  • [ISSN] 0012-3706
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


34. Newman E, Potmesil M, Ryan T, Marcus S, Hiotis S, Yee H, Norwood B, Wendell M, Muggia F, Hochster H: Neoadjuvant chemotherapy, surgery, and adjuvant intraperitoneal chemotherapy in patients with locally advanced gastric or gastroesophageal junction carcinoma: a phase II study. Semin Oncol; 2005 Dec;32(6 Suppl 9):S97-100
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A phase II trial, using neoadjuvant chemotherapy and intraperitoneal (IP) consolidation, was conducted in patients with locally advanced, potentially resectable gastric cancer or cancer of the gastroesophageal junction, both staged as T3N0, T4N0, or any TN1 or TN2 disease.
  • Evidence of primary-tumor downstaging was documented in at least one half of the patients.
  • Sites of first recurrences were outside the abdominal cavity in seven patients, in the liver in two, and in the abdominal cavity in four patients.

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. FLOXURIDINE .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16399443.001).
  • [ISSN] 0093-7754
  • [Journal-full-title] Seminars in oncology
  • [ISO-abbreviation] Semin. Oncol.
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase II; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 039LU44I5M / Floxuridine; 7673326042 / irinotecan; Q20Q21Q62J / Cisplatin; XT3Z54Z28A / Camptothecin
  •  go-up   go-down


35. Ferguson GG, Lee EW, Hunt SR, Ridley CH, Brandes SB: Management of the bladder during surgical treatment of enterovesical fistulas from benign bowel disease. J Am Coll Surg; 2008 Oct;207(4):569-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Patients were excluded if they had any history of abdominal cancer or pelvic radiation.
  • Twenty-six women and 48 men underwent celiotomy and segmental resection of the offending bowel and bowel side of the fistula.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18926461.001).
  • [ISSN] 1879-1190
  • [Journal-full-title] Journal of the American College of Surgeons
  • [ISO-abbreviation] J. Am. Coll. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


36. Lengelé B, Scalliet P: Anatomical bases for the radiological delineation of lymph node areas. Part III: Pelvis and lower limbs. Radiother Oncol; 2009 Jul;92(1):22-33
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cancer spreads locally through direct infiltration into soft tissues, or at a distance by invading vascular structures, then migrating through the lymphatic or blood flow.
  • Although cancer cells carried in the blood can end in virtually any corner of the body, lymphatic migration is usually stepwise, through successive nodal stops, which can temporarily delay further progression.
  • Similarly, excision of cancer is often completed by lymphatic dissection.
  • Both in radiotherapy and in surgery, advanced knowledge of the lymphatic pathways relevant to any tumor location is an important information for treatment preparation and execution.
  • It also offers the first original classification for labeling the intrapelvic nodes, grouped in seven paired volumes (called levels I-VII), functionally linked with one another and lower abdominal levels by eight potential drainage pathways.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19095323.001).
  • [ISSN] 1879-0887
  • [Journal-full-title] Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • [ISO-abbreviation] Radiother Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Ireland
  • [Number-of-references] 27
  •  go-up   go-down


37. Kusunoki M, Ikeuchi H, Yanagi H, Noda M, Tonouchi H, Mohri Y, Uchida K, Inoue Y, Kobayashi M, Miki C, Yamamura T: Bioresorbable hyaluronate-carboxymethylcellulose membrane (Seprafilm) in surgery for rectal carcinoma: a prospective randomized clinical trial. Surg Today; 2005;35(11):940-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: To evaluate the effectiveness of Seprafilm in preventing abdominal adhesions after radical resection of rectal carcinoma, and to observe whether Seprafilm had any adverse effects in patients treated with radiotherapy and chemotherapy.
  • CONCLUSION: Seprafilm effectively reduced abdominal adhesions in chemoradiated patients, and had no adverse effects on the oncologic results of fully introduced adjuvant therapy.
  • [MeSH-minor] Absorbable Implants. Adult. Aged. Combined Modality Therapy. Female. Humans. Laparoscopy. Male. Middle Aged. Postoperative Complications / prevention & control. Tissue Adhesions / diagnosis. Tissue Adhesions / prevention & control. Wound Healing

  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. HYALURONIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dis Colon Rectum. 1999 May;42(5):614-8; discussion 618-9 [10344683.001]
  • [Cites] Eur J Surg Suppl. 1997;(577):40-8 [9076451.001]
  • [Cites] Surg Today. 1996;26(12):1033-5 [9017971.001]
  • [Cites] JAMA. 2000 Aug 23-30;284(8):1008-15 [10944647.001]
  • [Cites] Int J Oncol. 1998 Oct;13(4):653-7 [9735391.001]
  • [Cites] Dis Colon Rectum. 2002 Mar;45(3):334-41; discussion 341-4 [12068190.001]
  • [Cites] Cancer Res. 2001 Feb 1;61(3):1029-37 [11221829.001]
  • [Cites] Br J Surg. 1997 Sep;84(9):1277-80 [9313713.001]
  • [Cites] Dis Colon Rectum. 2002 Oct;45(10):1376-80 [12394438.001]
  • [Cites] Ann Surg. 2002 Feb;235(2):193-9 [11807358.001]
  • [Cites] J Am Coll Surg. 1996 Oct;183(4):297-306 [8843257.001]
  • [Cites] Lancet. 2001 Oct 20;358(9290):1291-304 [11684209.001]
  • (PMID = 16249848.001).
  • [ISSN] 0941-1291
  • [Journal-full-title] Surgery today
  • [ISO-abbreviation] Surg. Today
  • [Language] eng
  • [Publication-type] Journal Article; Randomized Controlled Trial
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Membranes, Artificial; 0 / Seprafilm; 9004-61-9 / Hyaluronic Acid
  •  go-up   go-down


38. Auranen A, Grénman S: Radiation therapy and biological compounds for consolidation therapy in advanced ovarian cancer. Int J Gynecol Cancer; 2008 Mar-Apr;18 Suppl 1:44-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radiation therapy and biological compounds for consolidation therapy in advanced ovarian cancer.
  • In women with advanced epithelial ovarian cancer, tested maintenance and consolidation strategies following first-line chemotherapy include high-dose chemotherapy, radiation therapy, intraperitoneal radionuclides including those linked to an antibody, and biological and immunologic agents.
  • This review focuses on the current understanding of the benefit of radiation therapy and biological agents used as consolidation in women with advanced ovarian cancer.
  • Whole abdominal radiation has given promising results only in the subgroup of patients with pathologic complete response.
  • Randomized trials with these agents have not demonstrated any significant improvement in the overall survival of ovarian cancer patients.
  • Currently, two ongoing studies (GOG 218, ICON7) are examining the potential of bevacizumab in the maintenance therapy of advanced epithelial ovarian cancer.
  • [MeSH-minor] Combined Modality Therapy. Female. Humans. Neoplasm Staging

  • Genetic Alliance. consumer health - Ovarian cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • MedlinePlus Health Information. consumer health - Radiation Therapy.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18336400.001).
  • [ISSN] 1525-1438
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Immunologic Factors
  •  go-up   go-down


39. Ota Y, Minamide J, Takata K, Aoyama N: [A case of advanced esophageal cancer that has come back eight years after combined modality therapy]. Gan To Kagaku Ryoho; 2009 Nov;36(12):2442-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of advanced esophageal cancer that has come back eight years after combined modality therapy].
  • In February 1992, right thoracotomy subtotal thoracic esophagectomy was performed after performing preoperative chemotherapy (FP therapy) for advanced esophageal cancer for two courses.
  • The pathological diagnosis was Mt, mod. diff. sqcc, mp, n4 (#2: 1/13, #9: 3/4), ly2, v0, stage IVa.
  • As we found lymph node metastasis surrounding the root of celiac artery and right renal vein by an abdominal CT in October 1999, nedaplatin+5-FU therapy was performed for 5 courses/24 weeks as second-line chemotherapy, and furthermore, a radiation therapy, linac 50 Gy was performed.
  • We have experienced a case of advanced esophageal cancer that has come back eight years after combined modality therapy, and after that, the patient could obtain a long-term survival with a marked effect of chemotherapy.
  • [MeSH-minor] Aged. Antimetabolites, Antineoplastic / administration & dosage. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Chemotherapy, Adjuvant. Combined Modality Therapy. Female. Fluorouracil. Humans. Neoplasm Recurrence, Local. Organoplatinum Compounds / administration & dosage. Time Factors

  • Genetic Alliance. consumer health - Esophageal Cancer.
  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20037450.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0 / Organoplatinum Compounds; 8UQ3W6JXAN / nedaplatin; U3P01618RT / Fluorouracil
  •  go-up   go-down


40. Nakazawa T, Ohara H, Sano H, Ando T, Imai H, Takada H, Hayashi K, Kitajima Y, Joh T: Difficulty in diagnosing autoimmune pancreatitis by imaging findings. Gastrointest Endosc; 2007 Jan;65(1):99-108
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Abdominal US showed multiple low-echoic masses in 1 case and a single mass in 3 cases.
  • Six patients were misdiagnosed with pancreatic cancer and 2 with bile-duct cancer.
  • Another 3 cases were diagnosed with pancreatic cancer because of segmental stenosis of the main pancreatic duct and no or focal enlargement of the pancreas.
  • [MeSH-major] Autoimmune Diseases / diagnosis. Pancreatitis / diagnosis
  • [MeSH-minor] Bile Duct Neoplasms / diagnosis. Constriction, Pathologic. Humans. Pancreatic Cyst / diagnosis. Pancreatic Ducts / pathology. Pancreatic Ducts / radiography. Pancreatic Ducts / ultrasonography. Pancreatic Neoplasms / diagnosis. Retrospective Studies. Tomography, X-Ray Computed


41. Pectasides D, Pectasides E, Psyrri A: Granulosa cell tumor of the ovary. Cancer Treat Rev; 2008 Feb;34(1):1-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Granulosa cell tumor of the ovary.
  • GCTs are characterized by long natural history and their tendency to recur years after the initial diagnosis.
  • Occasionally, tumor rupture causes abdominal pain and hemoperitoneum.
  • Surgery is the mainstay of initial management for histological diagnosis, appropriate staging and debulking surgery.
  • In postmenopausal women and those with more advanced disease a total abdominal hysterectomy with bilateral salpingo-oophorectomy is the appropriate surgical treatment.
  • The role of post-operative chemo- or radiotherapy in stage I disease and those with completely resected tumor has not been defined.
  • Due to their tendency to recur years after the initial diagnosis, prolonged surveillance is essential.
  • [MeSH-major] Granulosa Cell Tumor / diagnosis. Granulosa Cell Tumor / therapy. Ovarian Neoplasms / diagnosis. Ovarian Neoplasms / therapy
  • [MeSH-minor] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Biomarkers, Tumor / analysis. Chemotherapy, Adjuvant. Combined Modality Therapy. Disease-Free Survival. Estradiol / analysis. Female. Humans. Neoplasm Recurrence, Local. Prognosis. Radiotherapy, Adjuvant

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • The Weizmann Institute of Science GeneCards and MalaCards databases. gene/protein/disease-specific - MalaCards for granulosa cell tumor of the ovary .
  • Hazardous Substances Data Bank. ESTRADIOL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17945423.001).
  • [ISSN] 0305-7372
  • [Journal-full-title] Cancer treatment reviews
  • [ISO-abbreviation] Cancer Treat. Rev.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 4TI98Z838E / Estradiol
  • [Number-of-references] 99
  •  go-up   go-down


42. Rappeport ED, Loft A: Liver metastases from colorectal cancer: imaging with superparamagnetic iron oxide (SPIO)-enhanced MR imaging, computed tomography and positron emission tomography. Abdom Imaging; 2007 Sep-Oct;32(5):624-34
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Liver metastases from colorectal cancer: imaging with superparamagnetic iron oxide (SPIO)-enhanced MR imaging, computed tomography and positron emission tomography.
  • The literature about superparamagnetic iron oxide-enhanced MR imaging, computed tomography (CT) and PET (positron emission tomography using fluorine-18 labelled fluoro-deoxy-glucose) in detection of liver metastases (LM) from colorectal cancer is reviewed in this update.
  • PET or PET/CT can be used for detection of extra-hepatic tumor before liver surgery.
  • [MeSH-major] Colorectal Neoplasms / diagnosis. Colorectal Neoplasms / pathology. Contrast Media / pharmacology. Diagnostic Imaging / methods. Ferric Compounds / pharmacology. Liver Neoplasms / diagnosis. Liver Neoplasms / secondary. Magnetic Resonance Imaging / methods. Positron-Emission Tomography / methods. Tomography, X-Ray Computed / methods
  • [MeSH-minor] Humans. Liver / pathology. Metals. Neoplasm Metastasis. Reference Standards. Sensitivity and Specificity. Treatment Outcome


43. Connolly PT, Teubner A, Lees NP, Anderson ID, Scott NA, Carlson GL: Outcome of reconstructive surgery for intestinal fistula in the open abdomen. Ann Surg; 2008 Mar;247(3):440-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Outcome of reconstructive surgery for intestinal fistula in the open abdomen.
  • OBJECTIVE: To determine factors which influence the outcome of surgical techniques to close enterocutaneous fistulas within the open abdomen.
  • SUMMARY BACKGROUND DATA: Enterocutaneous fistulation within an open abdominal wound is associated with considerable morbidity and mortality.
  • METHODS: Sixty-one patients undergoing 63 operations to close enterocutaneous fistulas associated with open abdominal wounds were referred to a national center for further management.
  • Once sepsis had been eradicated, nutritional status restored and local conditions in the abdomen judged to be suitable, fistulas were resected and the abdominal wall reconstructed by suture repair with and without component separation, or by suture repair in combination with absorbable or nonabsorbable prosthetic mesh.
  • Major complications, including postoperative respiratory and surgical site infection occurred in 52 of 63 (82.5%) procedures.
  • Refistulation occurred in 7 cases (11.1%) but was more common when the abdominal wall was reconstructed with prosthetic mesh (7 of 29, 24.1%) than with sutures (0 of 34, 0%).
  • CONCLUSIONS: Simultaneous reconstruction of the intestinal tract and abdominal wall remains associated with a high complication rate, justifying the management of such patients in specialized units.
  • Simultaneous reconstruction of the abdominal wall with prosthetic mesh is associated with a particularly high incidence of recurrent postoperative fistulation and should be avoided if possible.
  • [MeSH-major] Abdominal Injuries / surgery. Intestinal Fistula / surgery
  • [MeSH-minor] Abdominal Wall / surgery. Adult. Female. Follow-Up Studies. Humans. Male. Middle Aged. Postoperative Complications. Surgical Mesh. Suture Techniques. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18376187.001).
  • [ISSN] 0003-4932
  • [Journal-full-title] Annals of surgery
  • [ISO-abbreviation] Ann. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


44. Wehrmann T, Riphaus A, Frenz MB, Martchenko K, Stergiou N: Endoscopic pancreatic duct stenting for relief of pancreatic cancer pain. Eur J Gastroenterol Hepatol; 2005 Dec;17(12):1395-400
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endoscopic pancreatic duct stenting for relief of pancreatic cancer pain.
  • [MeSH-major] Abdominal Pain / therapy. Palliative Care / methods. Pancreatic Ducts / pathology. Pancreatic Neoplasms / complications. Stents


45. Bronzino P, Abbo L, Barisone P, Dezzani C, Genovese AM, Iannucci P, Ippoliti M, Sacchi M, Aimo I: [Acute abdomen from ruptured adrenal pheochromocytoma: case report]. G Chir; 2005 Jan-Feb;26(1-2):25-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Acute abdomen from ruptured adrenal pheochromocytoma: case report].
  • The pheochromocytoma is a very rare neoplasm, which originates in 98% of cases in the adrenal medulla; it is often bilateral in familial syndromes.
  • In this article the Authors report a case of a young woman with a large adrenal pheochromocytoma, that presented by an acute abdomen; the treatment was explorative laparotomy with unilateral adrenalectomy.
  • Therapy of this tumour is founded on surgery, plus chemiotherapy radiotherapy or treatment with 131I-MIBG (iodine-131-metaiodobenzylguanidine in malignant cases (10%).
  • [MeSH-major] Abdomen, Acute / etiology. Adrenal Gland Neoplasms / complications. Pheochromocytoma / complications
  • [MeSH-minor] Adrenalectomy. Adult. Female. Follow-Up Studies. Humans. Immunohistochemistry. Radiography, Abdominal. Rupture, Spontaneous. Time Factors. Tomography, X-Ray Computed


46. Kobayashi A, Miwa S, Nakata T, Miyagawa S: Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma. Br J Surg; 2010 Jan;97(1):56-64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Sites of initial disease recurrence were classified as locoregional (porta hepatis) or distant (intrahepatic, peritoneal, para-aortic lymph nodal or extra-abdominal).
  • Positive nodal involvement and high International Union Against Cancer tumour (T) stage were independent prognostic factors associated with distant metastasis.
  • [MeSH-major] Bile Duct Neoplasms / surgery. Bile Ducts, Intrahepatic / surgery. Cholangiocarcinoma / surgery. Hepatectomy / methods. Neoplasm Recurrence, Local / etiology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Neoplasm Metastasis. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Bile Duct Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
  • (PMID = 19937985.001).
  • [ISSN] 1365-2168
  • [Journal-full-title] The British journal of surgery
  • [ISO-abbreviation] Br J Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


47. Liu TG, Huang Y, Cui DD, Huang XB, Mao SH, Ji LL, Song HB, Yi C: Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice. BMC Cancer; 2009;9:250
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice.
  • Tumor volume, inhibitive rate and necrosis rate were estimated.
  • Necrosis of tumor and signals of blood flow as well as dynamic parameters of arterial blood flow in tumors such as peak systolic velocity (PSV) and resistive index (RI) were detected by color Doppler ultrasound.
  • In addition, expression of vascular endothelial cell growth factor (VEGF) and CD31 were observed by immunohistochemstry, and microvessel density (MVD) of the tumor tissues was assessed by CD31 immunohistochemical analysis.
  • Combined therapy with ginsenoside Rg3 and gemcitabine not only enhanced efficacy on suppression of tumor growth and prolongation of the survival, but also increased necrosis rate of tumor significantly.
  • CONCLUSION: Ginsenoside Rg3 combined with gemcitabine may significantly inhibit angiogenesis and growth of lung cancer and improve survival and quality of life of tumor-bearing mice.
  • The combination of chemotherapy and anti-angiogenic drugs may be an innovative and promising therapeutic strategy in the experimental treatment of human lung cancer.
  • [MeSH-minor] Animals. Cell Growth Processes / drug effects. Deoxycytidine / administration & dosage. Deoxycytidine / adverse effects. Deoxycytidine / analogs & derivatives. Female. Ginsenosides / administration & dosage. Ginsenosides / adverse effects. Humans. Mice. Mice, Inbred BALB C. Neovascularization, Pathologic / drug therapy. Neovascularization, Pathologic / pathology. Random Allocation. Tumor Cells, Cultured. Vascular Endothelial Growth Factor A / biosynthesis

  • Genetic Alliance. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Biochem Pharmacol. 1999 Dec 1;58(11):1685-93 [10571242.001]
  • [Cites] Lung Cancer. 2009 Nov;66(2):169-75 [19223090.001]
  • [Cites] J Clin Invest. 2000 Apr;105(8):R15-24 [10772661.001]
  • [Cites] Cancer Res. 2001 Apr 15;61(8):3369-72 [11309294.001]
  • [Cites] Clin Cancer Res. 2001 Aug;7(8):2527-36 [11489836.001]
  • [Cites] Cancer Res. 2001 Oct 15;61(20):7501-6 [11606386.001]
  • [Cites] Anticancer Res. 2001 Jul-Aug;21(4A):2287-91 [11724284.001]
  • [Cites] Cancer Res. 2002 Feb 1;62(3):789-95 [11830534.001]
  • [Cites] Cancer Res. 2002 Oct 1;62(19):5597-602 [12359773.001]
  • [Cites] Cancer Res. 2003 Jan 15;63(2):382-5 [12543791.001]
  • [Cites] J Clin Pharm Ther. 2003 Feb;28(1):5-15 [12605613.001]
  • [Cites] Clin Cancer Res. 2003 Mar;9(3):1211-7 [12631627.001]
  • [Cites] Pharmacol Biochem Behav. 2003 Jun;75(3):687-700 [12895687.001]
  • [Cites] N Engl J Med. 1971 Nov 18;285(21):1182-6 [4938153.001]
  • [Cites] J Natl Cancer Inst. 1990 Jan 3;82(1):4-6 [1688381.001]
  • [Cites] Cancer Res. 1990 Jul 15;50(14):4417-22 [2364394.001]
  • [Cites] Ultrasound Med Biol. 1990;16(6):553-9 [2238263.001]
  • [Cites] N Engl J Med. 1991 Jan 3;324(1):1-8 [1701519.001]
  • [Cites] J Ethnopharmacol. 1992 Feb;36(1):27-38 [1501490.001]
  • [Cites] J Clin Oncol. 1995 Mar;13(3):765-82 [7533829.001]
  • [Cites] Semin Oncol. 1995 Aug;22(4 Suppl 11):19-25 [7481840.001]
  • [Cites] Invest Radiol. 1998 Jan;33(1):39-44 [9438508.001]
  • [Cites] Eur J Cancer. 1999 May;35(5):808-14 [10505043.001]
  • [Cites] Anticancer Drugs. 2005 Jun;16(5):551-7 [15846121.001]
  • [Cites] Int J Surg Pathol. 2005 Apr;13(2):135-42 [15864375.001]
  • [Cites] Oncology. 2005;69(1):81-7 [16088235.001]
  • [Cites] Breast. 2005 Dec;14(6):466-79 [16199161.001]
  • [Cites] Ann Oncol. 2006 Feb;17(2):232-8 [16322118.001]
  • [Cites] Am J Epidemiol. 2006 Apr 1;163(7):645-53 [16484447.001]
  • [Cites] Biochem Pharmacol. 2006 Aug 14;72(4):437-45 [16793023.001]
  • [Cites] Gene Ther. 2007 Jan;14(2):108-17 [16943854.001]
  • [Cites] Neurosci Lett. 2007 Mar 26;415(2):113-7 [17296266.001]
  • [Cites] Chin Med J (Engl). 2007 Apr 5;120(7):584-8 [17442207.001]
  • [Cites] Breast Cancer. 2007;14(2):163-73 [17485901.001]
  • [Cites] Mini Rev Med Chem. 2007 Jun;7(6):649-61 [17584162.001]
  • [Cites] Indian J Ophthalmol. 2007 Nov-Dec;55(6):437-9 [17951900.001]
  • [Cites] Breast. 2007 Dec;16 Suppl 2:S17-9 [17707641.001]
  • [Cites] Ann Surg Oncol. 2008 Mar;15(3):906-14 [18163171.001]
  • [Cites] Arch Toxicol. 2008 Mar;82(3):183-95 [17874070.001]
  • [Cites] Melanoma Res. 2008 Oct;18(5):322-9 [18781130.001]
  • [Cites] Expert Rev Neurother. 2008 Oct;8(10):1457-73 [18928341.001]
  • [Cites] Cardiovasc Intervent Radiol. 2008 Nov-Dec;31(6):1133-40 [18584240.001]
  • [Cites] Cancer Biother Radiopharm. 2008 Oct;23(5):647-53 [18999937.001]
  • [Cites] J Clin Invest. 2000 Apr;105(8):1045-7 [10772648.001]
  • (PMID = 19624862.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Ginsenosides; 0 / Vascular Endothelial Growth Factor A; 0W860991D6 / Deoxycytidine; 14197-60-5 / ginsenoside Rg3; B76N6SBZ8R / gemcitabine
  • [Other-IDs] NLM/ PMC2721848
  •  go-up   go-down


48. Kao HK, Chang KP, Ching WC, Tsao CK, Cheng MH, Wei FC: Postoperative morbidity and mortality of head and neck cancers in patients with liver cirrhosis undergoing surgical resection followed by microsurgical free tissue transfer. Ann Surg Oncol; 2010 Feb;17(2):536-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Postoperative morbidity and mortality of head and neck cancers in patients with liver cirrhosis undergoing surgical resection followed by microsurgical free tissue transfer.
  • BACKGROUND: The aim of this study was to evaluate the association and the related risk factors between postoperative complications and mortality and the severity of liver cirrhosis in head and neck cancer patients undergoing tumor ablation followed by microsurgical free tissue transfer.
  • The diagnosis of liver cirrhosis was made mainly by abdominal ultrasonography.
  • RESULTS: There were 60 men and 2 women enrolled.
  • [MeSH-minor] Adult. Aged. Comorbidity. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Staging. Retrospective Studies. Survival Rate. Treatment Outcome

  • MedlinePlus Health Information. consumer health - After Surgery.
  • MedlinePlus Health Information. consumer health - Cirrhosis.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19904572.001).
  • [ISSN] 1534-4681
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


49. Alderman AK, Kuzon WM Jr, Wilkins EG: A two-year prospective analysis of trunk function in TRAM breast reconstructions. Plast Reconstr Surg; 2006 Jun;117(7):2131-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To address the concerns of abdominal wall morbidity with transverse rectus abdominis musculocutaneous (TRAM) flap reconstructions, the authors prospectively evaluated the long-term effects of postmastectomy breast reconstruction on trunk function using objective clinical measures.
  • CONCLUSIONS: The authors found that (1) breast cancer patients with TRAM reconstructions had a less than 20 percent long-term deficit in trunk flexion peak torque and (2) there was no significant difference in trunk function between patients receiving pedicle and free TRAM reconstructions.

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Reconstruction.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16772906.001).
  • [ISSN] 1529-4242
  • [Journal-full-title] Plastic and reconstructive surgery
  • [ISO-abbreviation] Plast. Reconstr. Surg.
  • [Language] eng
  • [Publication-type] Clinical Trial; Comparative Study; Journal Article; Multicenter Study
  • [Publication-country] United States
  •  go-up   go-down


50. Shishido T, Miura I, Watanabe K, Noda H, Hayashi K, Okegawa T, Nutahara K, Higashihara E: [Urachal anomalies and tumor: clinical investigation of 14 cases]. Hinyokika Kiyo; 2005 Nov;51(11):731-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Urachal anomalies and tumor: clinical investigation of 14 cases].
  • During the past 9-year period, there have been 14 patients with urachal disease consisting of 10 with urachal abscess and 4 with urachal cancer.
  • The 4 patients with urachal cancer consisted of 2 males and 2 females aged 48-81 years (mean, 57 years).
  • As symptoms, lower abdominal pain was frequently observed in the patients with persistent urachus with abscess and gross hematuria in those with urachal cancer.
  • The preoperative diagnosis was urachal cancer in 6 patients, and pathological examination showed 4 patients with adenocarcinoma, 1 with inflammatory granuloma, and 1 with pseudosarcoma.
  • Of the patients with urachal cancer, 1 underwent total cystectomy and the other 3 underwent total urachal resection and partial cystectomy.
  • In 2 patients with persistent urachus with abscess, the differentiation between abscess and malignant tumor was difficult.
  • [MeSH-major] Abscess / diagnosis. Neoplasms / diagnosis. Urachus / abnormalities. Urachus / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Diagnosis, Differential. Female. Humans. Magnetic Resonance Imaging. Male. Prognosis. Urachal Cyst / diagnosis

  • MedlinePlus Health Information. consumer health - Abscess.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16363704.001).
  • [ISSN] 0018-1994
  • [Journal-full-title] Hinyokika kiyo. Acta urologica Japonica
  • [ISO-abbreviation] Hinyokika Kiyo
  • [Language] jpn
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


51. Mullen JT, Lee JH, Gomez HF, Ross WA, Fukami N, Wolff RA, Abdalla EK, Vauthey JN, Lee JE, Pisters PW, Evans DB: Pancreaticoduodenectomy after placement of endobiliary metal stents. J Gastrointest Surg; 2005 Nov;9(8):1094-104; discussion 1104-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Contemporary treatment programs for patients with potentially resectable pancreatic cancer often involve preoperative therapy.
  • The incidence of major perioperative complications was similar between the two groups, including the rates of pancreatic fistula, intra-abdominal abscess, and wound infection.
  • We conclude that the use of expandable metal stents does not increase PD-associated perioperative morbidity or mortality, and as such an expandable metal stent is our preferred method of biliary decompression in patients with symptomatic malignant distal bile duct obstruction in whom surgery is not anticipated, or in whom there is a significant delay in the time to surgery.

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Gastrointest Surg. 2006 Jul-Aug;10(7):1095; author reply 1096-7 [16843882.001]
  • [Cites] Ann Surg. 1999 Aug;230(2):131-42 [10450725.001]
  • [Cites] Ann Surg Oncol. 2001 Mar;8(2):123-32 [11258776.001]
  • [Cites] Am J Gastroenterol. 2005 Sep;100(9):2056-61 [16128952.001]
  • [Cites] J Gastrointest Surg. 2000 May-Jun;4(3):258-67; discussion 267-8 [10769088.001]
  • [Cites] Ann Surg Oncol. 2000 Aug;7(7):484-9 [10947015.001]
  • [Cites] J Gastrointest Surg. 2004 Dec;8(8):935-49; discussion 949-50 [15585381.001]
  • [Cites] Lancet. 1992 Dec 19-26;340(8834-8835):1488-92 [1281903.001]
  • [Cites] Gut. 2004 May;53(5):729-34 [15082593.001]
  • [Cites] J Clin Oncol. 2000 Feb;18(4):860-7 [10673529.001]
  • [Cites] Gastrointest Endosc. 2003 Feb;57(2):178-82 [12556780.001]
  • [Cites] Surg Oncol Clin N Am. 2004 Oct;13(4):639-61, ix [15350939.001]
  • [Cites] Ann Surg. 2001 Jul;234(1):47-55 [11420482.001]
  • [Cites] Gastrointest Endosc. 1998 Jan;47(1):1-7 [9468416.001]
  • [Cites] Gastrointest Endosc. 2004 Oct;60(4):640-4 [15472699.001]
  • [Cites] J Clin Oncol. 2002 May 15;20(10):2537-44 [12011133.001]
  • [Cites] Arch Surg. 1998 Feb;133(2):149-54 [9484726.001]
  • [Cites] Arch Surg. 1992 Nov;127(11):1335-9 [1359851.001]
  • (PMID = 16269380.001).
  • [ISSN] 1091-255X
  • [Journal-full-title] Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
  • [ISO-abbreviation] J. Gastrointest. Surg.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Metals
  •  go-up   go-down


52. Lee SE, Jeon EJ, Oh JH, Shim KH, Lee J, Kim EH, Choi SW, Min KO: [A case of advanced gastric cancer with perianal skin metastasis]. Korean J Gastroenterol; 2008 Jan;51(1):40-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of advanced gastric cancer with perianal skin metastasis].
  • The most common metastatic sites of gastric cancer are liver, lung, bone and adrenal gland.
  • However, skin metastases from gastric cancer are relatively rare.
  • We herein report a case of advanced gastric cancer with perianal skin metastasis in a 70-year-old male.
  • Endoscopy and abdominal CT scan demonstrated the stage IV gastric cancer.
  • We suspected that the perianal lesion was originated from gastric cancer.
  • [MeSH-major] Skin Neoplasms / diagnosis. Skin Neoplasms / secondary. Stomach Neoplasms / diagnosis
  • [MeSH-minor] Aged. Anal Canal. Humans. Male. Neoplasm Staging

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18349561.001).
  • [ISSN] 1598-9992
  • [Journal-full-title] The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
  • [ISO-abbreviation] Korean J Gastroenterol
  • [Language] kor
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Korea (South)
  •  go-up   go-down


53. Zhang JW, Sun YM, Bian ZM, Shi SS, Wang CF, Zhao P: [Small pancreatic cancer diagnosis and prognosis]. Zhonghua Zhong Liu Za Zhi; 2009 May;31(5):375-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Small pancreatic cancer diagnosis and prognosis].
  • OBJECTIVE: To investigate the clinicopathological characteristics, diagnostic methods and prognosis of small pancreatic cancer.
  • METHODS: From May 2000 to January 2007, 89 patients with pancreatic cancer underwent surgery in our hospital.
  • Of those, 14 had a tumor < or = 2 cm in diameter (small tumor group), and the other 75 had a tumor >2 cm in diameter (controlled group).
  • RESULTS: In the small pancreatic cancer group, CT and MRI detected 66.7% (8/12) and 77.8% (7/9) of the tumors, respectively.
  • However, the tumor size was not shown to be an independent risk factor (OR value = 1.45, P = 0.971).
  • CONCLUSION: CT and MRI are valuable in detecting small pancreatic cancer.
  • Small pancreatic cancers are likely to have a better prognosis when compared with larger ones.
  • Lymph node metastasis and local infiltration are independent predictors of prognosis but not tumor size.
  • [MeSH-major] Pancreatic Neoplasms / diagnosis. Retroperitoneal Space / pathology. Serous Membrane / pathology
  • [MeSH-minor] Aged. Female. Follow-Up Studies. Humans. Lymphatic Metastasis. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging. Proportional Hazards Models. Retrospective Studies. Survival Rate. Tomography, X-Ray Computed. Tumor Burden

  • Genetic Alliance. consumer health - Pancreatic cancer.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19799088.001).
  • [ISSN] 0253-3766
  • [Journal-full-title] Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • [ISO-abbreviation] Zhonghua Zhong Liu Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


54. Ackerman I: Adjuvant pelvic radiation therapy in endometrial cancer: The pro argument. Int J Gynecol Cancer; 2010 Oct;20(11 Suppl 2):S67-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adjuvant pelvic radiation therapy in endometrial cancer: The pro argument.
  • Adjuvant external beam pelvic radiation therapy for stage I endometrial cancer has become increasingly confusing and controversial.
  • By using evidence from the literature, including the most recent randomized data, an argument is made for the use of external beam pelvic radiotherapy for a 63-year-old woman who has undergone a total abdominal hysterectomy and bilateral salpingo-oophorectomy for a grade 2 endometrioid adenocarcinoma of the uterus with 9 of 12 mm of invasion and the presence of lymphovascular space involvement.
  • [MeSH-major] Carcinoma, Endometrioid / prevention & control. Carcinoma, Endometrioid / radiotherapy. Endometrial Neoplasms / prevention & control. Endometrial Neoplasms / radiotherapy. Neoplasm Recurrence, Local / prevention & control
  • [MeSH-minor] Female. Humans. Middle Aged. Neoplasm Staging. Radiotherapy, Adjuvant. Randomized Controlled Trials as Topic. Risk Assessment. Treatment Outcome

  • Genetic Alliance. consumer health - Endometrial cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21053530.001).
  • [ISSN] 1525-1438
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  •  go-up   go-down


55. Hoya Y, Yamashita M, Sasaki T, Yanaga K: Laparoscopic intragastric full-thickness excision (LIFE) of early gastric cancer under flexible endoscopic control--introduction of new technique using animal. Surg Laparosc Endosc Percutan Tech; 2007 Apr;17(2):111-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic intragastric full-thickness excision (LIFE) of early gastric cancer under flexible endoscopic control--introduction of new technique using animal.
  • BACKGROUND: We have developed a new method for the treatment of stomach lesions in early gastric cancer, which we refer to as laparoscopic intragastric full-thickness excision under flexible endoscopic control.
  • The T-bar, after passing through the abdominal wall, is fixed outside the gastric wall.
  • The second trocar (trocar(2)) is placed at the subumbilical region in the abdominal cavity to accommodate the laparoscope, whereas the third trocars (trocar(3)) are percutaneously punctured into the abdominal cavity.
  • The gastrotomy site is sutured using instruments positioned through trocar(1) and trocar(3) under laparoscopy.
  • The stomach surgery is performed under gastroscopic guidance, whereas the intra-abdominal procedures are performed under laparoscopy.

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17450092.001).
  • [ISSN] 1530-4515
  • [Journal-full-title] Surgical laparoscopy, endoscopy & percutaneous techniques
  • [ISO-abbreviation] Surg Laparosc Endosc Percutan Tech
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


56. Cadili A, Bazarrelli A, Garg S, Bailey R: Survival in cystic neoplasms of the pancreas. Can J Gastroenterol; 2009 Aug;23(8):537-42
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Many pancreatic cysts are of undetermined malignant potential at presentation and remain so until surgically resected.
  • While the survival rates of patients with malignant cysts are known to be poor, survival rates in patients with undetermined pancreatic cysts are unknown.
  • All patients with a diagnosis of a neoplastic pancreatic cyst from 1994 to 2003 were identified at five different institutions in Edmonton, Alberta.
  • The data collected included patient age, sex, imaging modality, cyst location, cyst size, number of cysts, comorbid illnesses, history of upper abdominal surgery, previous cancer, previous or concurrent metastases, symptoms (pain, upper gastrointestinal bleeding, signs of biliary obstruction, nausea/vomiting), remarkable radiological features, elevated amylase or lipase, type of pancreatic surgery, final pathology (benign or malignant) and overall survival.
  • The median age at diagnosis for the patient population was 73 years, with 40 patients being women.

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AJR Am J Roentgenol. 2000 Jul;175(1):99-103 [10882255.001]
  • [Cites] J Am Coll Surg. 2008 Jan;206(1):17-27 [18155564.001]
  • [Cites] Ann Surg. 2004 May;239(5):651-7; discussion 657-9 [15082969.001]
  • [Cites] JOP. 2004 Sep;5(5):338-47 [15365200.001]
  • [Cites] Ann Surg. 1990 Oct;212(4):432-43; discussion 444-5 [2171441.001]
  • [Cites] Br J Surg. 1998 Nov;85(11):1484-6 [9823906.001]
  • [Cites] Aust N Z J Surg. 1998 Dec;68(12):844-6 [9885865.001]
  • [Cites] Hepatogastroenterology. 1998 Nov-Dec;45(24):2421-4 [9951936.001]
  • [Cites] Ann Surg. 1999 Aug;230(2):152-61 [10450728.001]
  • [Cites] Medicina (Kaunas). 2004;40(12):1180-8 [15630345.001]
  • [Cites] Radiographics. 2005 Nov-Dec;25(6):1471-84 [16284129.001]
  • [Cites] Am J Surg. 2006 Aug;192(2):148-54 [16860621.001]
  • [Cites] World J Surg. 2006 Aug;30(8):1553-9 [16773248.001]
  • [Cites] J Gastrointest Surg. 2007 Jul;11(7):820-6 [17440789.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 2007;14(4):401-9 [17653641.001]
  • [Cites] Dig Dis Sci. 2007 Oct;52(10):2653-9 [17404855.001]
  • [Cites] Arch Surg. 2003 Apr;138(4):427-3; discussion 433-4 [12686529.001]
  • (PMID = 19668796.001).
  • [ISSN] 0835-7900
  • [Journal-full-title] Canadian journal of gastroenterology = Journal canadien de gastroenterologie
  • [ISO-abbreviation] Can. J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Canada
  • [Other-IDs] NLM/ PMC2732173
  •  go-up   go-down


57. Morelli M, Noia R, Costantino A, Chiodo D, Mocciaro R, Caruso M, Cosco C, Lucia E, Curcio B, Gullì G, Amendola G, Zullo F: [Laparoscopic lymphadenectomy as treatment of endometrial cancer]. Minerva Ginecol; 2007 Apr;59(2):111-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Laparoscopic lymphadenectomy as treatment of endometrial cancer].
  • [Transliterated title] Linfoadenectomia laparoscopica nel trattamento del carcinoma endometriale.
  • AIM: This study compares the effects of laparoscopic lymphadenectomy versus those of abdominal lymphadenectomy in patients with endometrial cancer.
  • METHODS: A prospective randomized study was performed among 80 patients randomly assigned to laparoscopic lymphadenectomy and to abdominal lymphadenectomy in the treatment of endometrial cancer.
  • RESULTS: Forty patients were assigned to laparoscopic lymphadenectomy and 40 patients to abdominal lymphadenectomy.

  • Genetic Alliance. consumer health - Endometrial cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Minerva Ginecol. 2007 Aug;59(4):469 [17923838.001]
  • (PMID = 17505452.001).
  • [ISSN] 0026-4784
  • [Journal-full-title] Minerva ginecologica
  • [ISO-abbreviation] Minerva Ginecol
  • [Language] ita
  • [Publication-type] English Abstract; Journal Article; Randomized Controlled Trial
  • [Publication-country] Italy
  •  go-up   go-down


58. Mann CD, Norwood MG, Miller AS, Hemingway D, Leicester Colorectal Specialist Interest Group: Nonresectional palliative abdominal surgery for patients with advanced colorectal cancer. Colorectal Dis; 2010 Oct;12(10):1039-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nonresectional palliative abdominal surgery for patients with advanced colorectal cancer.
  • OBJECTIVE: Nonresectional palliative abdominal surgery (e.g. defunctioning stoma/bypass) may be appropriate for patients unsuitable for curative resection, to deal with complications of advanced colorectal malignancy such as obstruction.
  • METHOD: All patients undergoing palliative surgery without resection for colorectal carcinoma between July 1998 and January 2007 were identified from our prospectively compiled colorectal cancer database.
  • Data were extracted related to patients' demographics, presentation, tumour site, operative intervention, complications, oncological therapies, length of hospital stay and postoperative survival.
  • CONCLUSION: Nonresectional palliative abdominal surgery is associated with relatively high morbidity and mortality, particularly when performed in the emergency setting.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Colonoscopy. Female. Humans. Length of Stay / statistics & numerical data. Male. Middle Aged. Neoplasm Staging. Postoperative Complications. Prospective Studies. Statistics, Nonparametric. Survival Rate. Treatment Outcome

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Palliative Care.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2010 The Authors. Colorectal Disease © 2010 The Association of Coloproctology of Great Britain and Ireland.
  • (PMID = 19438888.001).
  • [ISSN] 1463-1318
  • [Journal-full-title] Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
  • [ISO-abbreviation] Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


59. Weinrich M, Lausberg HF, Pahl S, Schäfers HJ: A bronchogenic cyst of the right ventricular endocardium. Ann Thorac Surg; 2005 Feb;79(2):e13-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In a 73-year-old male patient with a history of prostate cancer, a right ventricular endoluminal tumor was diagnosed by echocardiography.
  • An endocardial papillary fibroelastoma or myxoma appeared possible; a malignant tumor could not be ruled out.
  • The tumor was resected using extracorporeal circulation and cardioplegic arrest.
  • [MeSH-major] Bronchogenic Cyst / diagnosis. Heart Diseases / diagnosis
  • [MeSH-minor] Aged. Dyspnea / etiology. Echocardiography. Heart Septum. Heart Ventricles. Humans. Male. Neoplasm Staging. Prostatic Neoplasms / complications

  • Genetic Alliance. consumer health - Bronchogenic Cyst.
  • MedlinePlus Health Information. consumer health - Heart Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15680797.001).
  • [ISSN] 1552-6259
  • [Journal-full-title] The Annals of thoracic surgery
  • [ISO-abbreviation] Ann. Thorac. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


60. Comert S, Vitrinel A, Akin Y, Mutlu GY, Tokuc G, Bakir B: Abdominal mass in a neonate: hepatoblastoma. Indian J Pediatr; 2007 Oct;74(10):956-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Abdominal mass in a neonate: hepatoblastoma.
  • A term neonate born to a 37 year old mother was admitted to our Neonatology Unit because of jaundice and abdominal distention.
  • Gastrointestinal examination revealed abdominal distention and a palpable abdominal mass in right upper quadrant.
  • Since accurate diagnosis could not be achieved by radiological studies a liver biopsy is performed.
  • [MeSH-minor] Biomarkers, Tumor / blood. Biopsy. Combined Modality Therapy. Diagnosis, Differential. Humans. Infant, Newborn. Jaundice, Neonatal / etiology. Liver / pathology. Male. Neoplasm Staging. Tomography, X-Ray Computed. Ultrasonography. alpha-Fetoproteins / analysis

  • Genetic Alliance. consumer health - Hepatoblastoma.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pediatr Radiol. 2000 Nov;30(11):794-7 [11100498.001]
  • [Cites] Hepatogastroenterology. 1998 Mar-Apr;45(20):459-61 [9638427.001]
  • [Cites] Eur J Pediatr Surg. 1995 Apr;5(2):72-6 [7542025.001]
  • [Cites] Cancer. 2004 Mar 1;100(5):1070-6 [14983504.001]
  • [Cites] Semin Neonatol. 2003 Oct;8(5):403-10 [15001128.001]
  • (PMID = 17978459.001).
  • [ISSN] 0973-7693
  • [Journal-full-title] Indian journal of pediatrics
  • [ISO-abbreviation] Indian J Pediatr
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / alpha-Fetoproteins
  •  go-up   go-down


61. Saksena M, Gervais D: Percutaneous renal tumor ablation. Abdom Imaging; 2009 Sep-Oct;34(5):582-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Percutaneous renal tumor ablation.
  • Recent increase in utilization of cross-sectional imaging has resulted in increased detection of early renal cancer.
  • Percutaneous ablation is a relatively new technique for the treatment of renal cancer.
  • This article provides an overview of clinical indications, technique, and results of percutaneous ablation of renal cancer.
  • [MeSH-major] Kidney Neoplasms / diagnosis. Kidney Neoplasms / surgery
  • [MeSH-minor] Biopsy. Catheter Ablation. Contrast Media. Cryosurgery. Humans. Magnetic Resonance Imaging. Postoperative Complications / diagnosis. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19089491.001).
  • [ISSN] 1432-0509
  • [Journal-full-title] Abdominal imaging
  • [ISO-abbreviation] Abdom Imaging
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media
  • [Number-of-references] 40
  •  go-up   go-down


62. Yazawa M, Kotake K, Matsui T, Asaga S: Abdominal dermolipectomy in laparotomy with stoma surgery: case report. Surg Technol Int; 2007;16:37-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Abdominal dermolipectomy in laparotomy with stoma surgery: case report.
  • In cases of morbid obesity, excessive soft tissue in the abdomen forms an apron-like deformity called panniculus because of rapid weight loss due to cancer.
  • In laparotomy with stoma aimed at cancer resection, obesity is reported as a major risk factor of stoma complications, one of the most frequent of which is necrosis.
  • In one patient in whom a laparotomy was performed through a midline incision, the authors also carried out an abdominal dermolipectomy aimed at reducing distortion of the abdominal wall in relation to the stoma.
  • [MeSH-major] Abdomen / surgery. Laparotomy / methods. Lipectomy / methods. Reconstructive Surgical Procedures / methods. Surgical Stomas

  • MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17429766.001).
  • [ISSN] 1090-3941
  • [Journal-full-title] Surgical technology international
  • [ISO-abbreviation] Surg Technol Int
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


63. Mishra G, Butler J, Ho C, Melin S, Case LD, Ennever PR, Magrinat GC, Bearden JD, Minotto DC, Howerton R, Levine E, Blackstock AW: Phase II trial of induction gemcitabine/CPT-11 followed by a twice-weekly infusion of gemcitabine and concurrent external beam radiation for the treatment of locally advanced pancreatic cancer. Am J Clin Oncol; 2005 Aug;28(4):345-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Phase II trial of induction gemcitabine/CPT-11 followed by a twice-weekly infusion of gemcitabine and concurrent external beam radiation for the treatment of locally advanced pancreatic cancer.
  • PURPOSE: This phase II trial of induction irinotecan/gemcitabine followed by twice-weekly gemcitabine and upper abdominal radiation was initiated to determine the activity of this regimen in patients with unresectable pancreatic cancer.
  • Following the induction, patients without disease progression received gemcitabine administered twice weekly (40 mg/m2/day) for 5 weeks concurrent with upper abdominal radiation (50.4 Gy over 5.5 weeks).
  • Characteristics included a median age of 67 years (range, 44-87 years) and 14 men (70%).
  • CONCLUSION: Induction irinotecan/gemcitabine followed by twice-weekly gemcitabine and upper abdominal radiation is feasible in patients with locally advanced pancreatic cancer.

  • Genetic Alliance. consumer health - Pancreatic cancer.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16062075.001).
  • [ISSN] 1537-453X
  • [Journal-full-title] American journal of clinical oncology
  • [ISO-abbreviation] Am. J. Clin. Oncol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / U10 CA81851
  • [Publication-type] Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0W860991D6 / Deoxycytidine; 7673326042 / irinotecan; B76N6SBZ8R / gemcitabine; XT3Z54Z28A / Camptothecin
  •  go-up   go-down


64. Pikaart DP, Holloway RW, Ahmad S, Finkler NJ, Bigsby GE 4th, Ortiz BH, Denardis SA: Clinical-pathologic and morbidity analyses of Types 2 and 3 abdominal radical hysterectomy for cervical cancer. Gynecol Oncol; 2007 Nov;107(2):205-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinical-pathologic and morbidity analyses of Types 2 and 3 abdominal radical hysterectomy for cervical cancer.
  • OBJECTIVE: To provide representative data analyses of surgical morbidity and clinical-pathologic factors for Types 2 and 3 abdominal radical hysterectomies (ARH) with pelvic+/-aortic node dissection performed in a private practice with a fellowship-training program.
  • METHODS: From 1997 to 2005, 329 cervical cancer patients underwent ARH with lymphadenectomy.
  • Tumor histology was 60% squamous, 37% adenocarcinoma, 1% adenosquamous, and 2% others.
  • [MeSH-minor] Adenocarcinoma / pathology. Adenocarcinoma / surgery. Adult. Carcinoma, Squamous Cell / pathology. Carcinoma, Squamous Cell / surgery. Female. Humans. Medical Records. Middle Aged. Neoplasm Staging. Retrospective Studies. Treatment Outcome


65. Seow-Choen F: The management of desmoids in patients with familial adenomatous polyposis (FAP). Acta Chir Iugosl; 2008;55(3):83-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Desmoids in FAP may occur extra-abdominally, or within the abdominal wall or most commonly intra-abdominally within the mesentery or retroperitoneal.
  • Mortality from desmoids is high in such patients and ranges from 18 to 31%, compared to peri-ampullary carcinomas at about 22% and cancer in the retained rectum at only about 8%.
  • Surgery should be reserved for extra-abdominal tumours alone and only when needed.
  • Surgery for intra-abdominal desmoids should really only be attempted for intestinal obstruction or ureteric obstruction.

  • Genetic Alliance. consumer health - Familial Adenomatous Polyposis (FAP).
  • Genetic Alliance. consumer health - Familial Polyposis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19069698.001).
  • [ISSN] 0354-950X
  • [Journal-full-title] Acta chirurgica Iugoslavica
  • [ISO-abbreviation] Acta Chir Iugosl
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Serbia
  • [Number-of-references] 21
  •  go-up   go-down


66. Canis M, Jardon K, Niro J, Rabischong B, Bourdel N, Botchorishvili R, Pouly JL, Mage G: [Endoscopic management of gynecological malignancies: an update. 2007]. Bull Acad Natl Med; 2007 Oct;191(7):1357-65; discussion 1365-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Coelioscopie et cancer en gynécologie: le point en 2007.
  • All the different surgical procedures used to treat gynecologic cancers have already been performed with the endoscopic approach.
  • However, the prospective randomized trials required to confirm the oncologic efficacy of this approach are still lacking in gynecology, whereas such studies are available for abdominal surgery.
  • Animal studies suggest that the risk of tumor dissemination in the non traumatized peritoneum may be higher after pneumoperitoneum than after laparotomy, and they also show the importance of the surgeon's experience and technique.
  • By controlling these parameters we may, in future, be able to create a peritoneal environment suitable for oncologic indications and thereby prevent or minimize the risk of peritoneal dissemination and postoperative tumor growth.
  • In endometrial cancer, the laparoscopic approach should be reserved for clinical stage I disease, if the volume of the uterus and local conditions are appropriate for vaginal extraction.
  • In cervical cancer, the laparoscopic approach should be reserved for patients with favorable prognostic factors (stage IB, less than 2 cm in diameter).
  • Laparoscopy is the gold standard for surgical diagnosis of adnexal masses, but puncture should be avoided whenever possible.
  • Surgical treatment of invasive ovarian cancer should use laparotomy, whatever the stage.
  • In contrast, restaging of early ovarian cancer initially managed as a benign mass is a good indication for the laparoscopic approach.
  • Laparoscopic management of tumors with low malignant potential should include complete staging of the peritoneum.
  • [MeSH-minor] Animals. Carcinoma / secondary. Carcinoma / surgery. Endometrial Neoplasms / surgery. Female. Humans. Neoplasm Seeding. Ovarian Neoplasms / diagnosis. Ovarian Neoplasms / pathology. Ovarian Neoplasms / surgery. Peritoneal Neoplasms / secondary. Pneumoperitoneum, Artificial / adverse effects. Pneumoperitoneum, Artificial / methods. Swine. Uterine Cervical Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18447057.001).
  • [ISSN] 0001-4079
  • [Journal-full-title] Bulletin de l'Académie nationale de médecine
  • [ISO-abbreviation] Bull. Acad. Natl. Med.
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 30
  •  go-up   go-down


67. Burkett AM, Cohn DE, Copeland LJ: Vaginal evisceration during intraperitoneal chemotherapy for advanced ovarian cancer. Gynecol Oncol; 2007 Feb;104(2):491-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vaginal evisceration during intraperitoneal chemotherapy for advanced ovarian cancer.
  • BACKGROUND: Recent studies have established that intraperitoneal chemotherapy is associated with improved outcomes compared with intravenous treatment in patients with advanced, optimally cytoreduced ovarian cancer, but at the expense of increased toxicity.
  • We present a case of vaginal evisceration during intraperitoneal chemotherapy for advanced ovarian cancer.
  • CASE: Following an optimal cytoreduction including total hysterectomy for advanced ovarian cancer, a 63-year-old woman underwent intraperitoneal chemotherapy.
  • It is possible that the increased abdominal pressure during intraperitoneal chemotherapy contributes to the risk for vaginal evisceration.


68. Mayorek N, Naftali-Shani N, Grunewald M: Diclofenac inhibits tumor growth in a murine model of pancreatic cancer by modulation of VEGF levels and arginase activity. PLoS One; 2010;5(9):e12715
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diclofenac inhibits tumor growth in a murine model of pancreatic cancer by modulation of VEGF levels and arginase activity.
  • Since inflammation is an important factor in the development of pancreatic tumors we explored the potential of diclofenac to inhibit tumor growth in mice inoculated with PANCO2 cells orthotopically.
  • METHODOLOGY/PRINCIPAL FINDINGS: We found that diclofenac treatment (30 mg/kg/bw for 11 days) of mice inoculated with PANC02 cells, reduced the tumor weight by 60%, correlating with increased apoptosis of tumor cells.
  • Indeed, diclofenac drastically decreased tumor vascularization by downregulating VEGF in the tumor and in abdominal cavity fluid.
  • Surprisingly, in contrast to other COX-2 inhibitors, diclofenac increased arginase activity/arginase 1 protein content in tumor stroma cells, peritoneal macrophages and white blood cells by 2.4, 4.8 and 2 fold, respectively.
  • We propose that the subsequent arginine depletion and decrease in NO levels, both in serum and peritoneal cavity, adds to tumor growth inhibition by malnourishment and poor vasculature development.
  • CONCLUSION/SIGNIFICANCE: In conclusion, diclofenac shows pronounced antitumoral properties in pancreatic cancer model that can contribute to further treatment development.
  • The ability of diclofenac to induce arginase activity in tumor stroma, peritoneal macrophages and white blood cells provides a tool to study a controversial issue of pro-and antitumoral effects of arginine depletion.

  • Genetic Alliance. consumer health - Pancreatic cancer.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • Hazardous Substances Data Bank. DICLOFENAC .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nature. 1978 Jun 29;273(5665):758-9 [661984.001]
  • [Cites] Nature. 1966 Jun 11;210(5041):1123-5 [6007179.001]
  • [Cites] In Vitro Cell Dev Biol. 1990 Feb;26(2):119-28 [1690206.001]
  • [Cites] Cancer Res. 1991 Jun 1;51(11):2932-9 [1903327.001]
  • [Cites] Nature. 1993 Apr 29;362(6423):841-4 [7683111.001]
  • [Cites] J Immunol Methods. 1994 Sep 14;174(1-2):231-5 [8083527.001]
  • [Cites] Methods Cell Biol. 1995;46:29-39 [7541886.001]
  • [Cites] Cancer Res. 1997 May 1;57(9):1625-9 [9134996.001]
  • [Cites] Scand J Clin Lab Invest. 1997 Aug;57(5):401-7 [9279965.001]
  • [Cites] Clin Pharmacokinet. 1997 Sep;33(3):184-213 [9314611.001]
  • [Cites] Dig Surg. 1998;15(2):105-9 [9845571.001]
  • [Cites] Cancer Res. 2005 Jun 15;65(12):5038-44 [15958546.001]
  • [Cites] J Exp Med. 2005 Oct 3;202(7):931-9 [16186186.001]
  • [Cites] Gastroenterology. 2006 Jun;130(7):2165-78 [16762637.001]
  • [Cites] J Surg Res. 2006 Jul;134(1):28-35 [16650862.001]
  • [Cites] N Engl J Med. 2006 Aug 31;355(9):873-84 [16943400.001]
  • [Cites] Cancer Res. 2007 Jan 1;67(1):309-17 [17210712.001]
  • [Cites] Ann Intern Med. 2007 Mar 6;146(5):376-89 [17339623.001]
  • [Cites] Cancer Res. 2007 May 1;67(9):4507-13 [17483367.001]
  • [Cites] Cancer Res. 2007 Aug 1;67(15):7068-71 [17652141.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18363-70 [18000042.001]
  • [Cites] Int Immunol. 2008 Feb;20(2):215-22 [18096562.001]
  • [Cites] Immunol Rev. 2008 Apr;222:180-91 [18364002.001]
  • [Cites] Neoplasia. 2008 Aug;10(8):782-96 [18670639.001]
  • [Cites] J Surg Res. 2008 Oct;149(2):319-28 [18639248.001]
  • [Cites] Histochem Cell Biol. 2008 Dec;130(6):1079-90 [18953558.001]
  • [Cites] Carcinogenesis. 2009 Mar;30(3):377-86 [19136477.001]
  • [Cites] Cancer Lett. 2009 May 8;277(1):91-100 [19138817.001]
  • [Cites] Mol Pharmacol. 2010 Apr;77(4):687-94 [20086033.001]
  • [Cites] Mol Cell Biol. 2000 Jun;20(11):4106-14 [10805752.001]
  • [Cites] J Clin Pharmacol. 2000 Oct;40(10):1109-20 [11028250.001]
  • [Cites] J Surg Oncol. 2000 Oct;75(2):146-54 [11064397.001]
  • [Cites] Cancer Res. 2001 Feb 1;61(3):1100-6 [11221839.001]
  • [Cites] Nat Rev Cancer. 2001 Oct;1(1):11-21 [11900248.001]
  • [Cites] Cancer Lett. 2002 Sep 26;183(2):155-62 [12065090.001]
  • [Cites] FEBS Lett. 2002 Dec 4;532(1-2):216-20 [12459493.001]
  • [Cites] Gastroenterology. 2003 Jun;124(7):1786-91 [12806612.001]
  • [Cites] Minerva Chir. 2004 Apr;59(2):99-111 [15238885.001]
  • [Cites] Clin Sci (Lond). 2004 Oct;107(4):371-9 [15157183.001]
  • [Cites] Cancer Res. 2004 Oct 15;64(20):7210-5 [15492235.001]
  • [Cites] Cancer. 1989 Nov 15;64(10):2035-44 [2804892.001]
  • (PMID = 20856806.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Angiogenesis Inhibitors; 0 / Antineoplastic Agents; 0 / Vascular Endothelial Growth Factor A; 144O8QL0L1 / Diclofenac; EC 3.5.3.1 / Arginase
  • [Other-IDs] NLM/ PMC2939880
  •  go-up   go-down


69. Kunoki N, Nishiyama R, Ryuzaki H, Oonishi M, Yamamoto T, Uno A, Ogawa M, Ogihara A, Tanaka N, Moriyama M, Sou K, Kinukawa N: [A case of alpha-fetoprotein-producing gastric cancer with hepatic metastasis successfully treated with combination chemotherapy]. Nihon Shokakibyo Gakkai Zasshi; 2008 Oct;105(10):1489-95
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of alpha-fetoprotein-producing gastric cancer with hepatic metastasis successfully treated with combination chemotherapy].
  • Abdominal ultrasonography showed 30mm great tumor in liver lateral segment area and gastric fiber showed type2 tumor which is AFP producing gastric cancer.
  • Multiple liver metastases were noted it by abdominal angiography.
  • We started FLAP(5-fluorouracil, leucovorin, etoposide, cisplatin)combination chemotherapy by a diagnosis of AFP producing gastric cancer StageIV.
  • It is reduction of a liver tumor after one course, and the stomach lesion almost disappeared after three courses end points.

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. ETOPOSIDE .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • Hazardous Substances Data Bank. LEUCOVORIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18840987.001).
  • [ISSN] 0446-6586
  • [Journal-full-title] Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
  • [ISO-abbreviation] Nihon Shokakibyo Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / alpha-Fetoproteins; 6PLQ3CP4P3 / Etoposide; Q20Q21Q62J / Cisplatin; Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil; FLEP regimen
  • [Number-of-references] 32
  •  go-up   go-down


70. Koo DH, Chang HM, Jung JY, Song JH, Lee JL, Ryu MH, Kim TW, Yook JH, Song JS, Lee JS, Kang YK: Cutaneous metastasis resembling acute dermatitis in patient with advanced gastric cancer. Clin Exp Dermatol; 2007 May;32(3):284-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cutaneous metastasis resembling acute dermatitis in patient with advanced gastric cancer.
  • The most common metastatic sites from gastric cancer are the liver, intra-abdominal lymph nodes, ovary and peritoneal cavity.
  • Cutaneous metastasis of gastric cancer is rare, and most cutaneous metastases are typically solitary, nodular, have a firm consistency, and are red or hyperpigmented.
  • We report a case of a 60-year-old woman with cutaneous metastasis of gastric cancer, whose facial skin showed painless pruritic eczema, resembling acute dermatitis.
  • She had earlier undergone a total gastrectomy for advanced gastric cancer in our hospital.
  • After 14 months, she developed eczematous facial lesions; the presumptive diagnosis was acute dermatitis.
  • However, skin biopsy unexpectedly revealed cutaneous metastasis of gastric cancer.
  • [MeSH-minor] Antineoplastic Agents / therapeutic use. Capecitabine. Cisplatin / therapeutic use. Deoxycytidine / analogs & derivatives. Deoxycytidine / therapeutic use. Diagnosis, Differential. Female. Fluorouracil / analogs & derivatives. Fluorouracil / therapeutic use. Humans. Middle Aged. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. CAPECITABINE .
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17263831.001).
  • [ISSN] 0307-6938
  • [Journal-full-title] Clinical and experimental dermatology
  • [ISO-abbreviation] Clin. Exp. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0W860991D6 / Deoxycytidine; 6804DJ8Z9U / Capecitabine; Q20Q21Q62J / Cisplatin; U3P01618RT / Fluorouracil
  •  go-up   go-down


71. Ellebaek Pedersen M, Qvist N, Bisgaard C, Kelly U, Bernhard A, Møller Pedersen S: Peritoneal microdialysis. Early diagnosis of anastomotic leakage after low anterior resection for rectosigmoid cancer. Scand J Surg; 2009;98(3):148-54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peritoneal microdialysis. Early diagnosis of anastomotic leakage after low anterior resection for rectosigmoid cancer.
  • BACKGROUND: The aim of the present study was to evaluate the efficacy and safety of intraperitoneal microdialysis in early detection of anastomotic leakage after low anterior resection for rectosigmoid cancer.
  • METHODS: In a series of 116 consecutive patients scheduled for low anterior resection for rectosigmoid cancer, a total of 50 patients consented to participate.
  • Two patients developed non-abdominal sepsis.
  • In the two patients with non-abdominal sepsis the values were within normal range.
  • CONCLUSION: Peritoneal microdialysis is a safe and promising tool in early diagnosis of anastomotic leakage after low anterior resection for rectosigmoid cancer.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Anastomosis, Surgical / adverse effects. Early Diagnosis. Female. Humans. Lactic Acid / metabolism. Male. Middle Aged. Predictive Value of Tests. Pyruvic Acid / metabolism

  • MedlinePlus Health Information. consumer health - After Surgery.
  • Hazardous Substances Data Bank. LACTIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19919919.001).
  • [ISSN] 1457-4969
  • [Journal-full-title] Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society
  • [ISO-abbreviation] Scand J Surg
  • [Language] eng
  • [Publication-type] Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 33X04XA5AT / Lactic Acid; 8558G7RUTR / Pyruvic Acid
  •  go-up   go-down


72. Heller L, Feledy JA, Chang DW: Strategies and options for free TRAM flap breast reconstruction in patients with midline abdominal scars. Plast Reconstr Surg; 2005 Sep;116(3):753-9; discussion 760-1
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Strategies and options for free TRAM flap breast reconstruction in patients with midline abdominal scars.
  • BACKGROUND: Patients who have a midline abdominal scar from previous abdominal surgery often present a challenge when use of a transverse rectus abdominis myocutaneous (TRAM) flap is desired for breast reconstruction.
  • In this study, the authors reviewed their experience with the TRAM flap for breast reconstruction in patients with midline abdominal scars to evaluate the various strategies used to optimize reconstructive outcomes.
  • METHODS: Between January of 1994 and December of 2001, 43 patients with a midline abdominal scar underwent unilateral autologous tissue breast reconstruction with a TRAM flap at The University of Texas, M. D.
  • Anderson Cancer Center.
  • RESULTS: The mean age of the midline abdominal scar was 13 years (range, 4 to 45 years).
  • In three patients with infraumbilical midline scars, a free TRAM flap was designed higher in the abdomen so that the superior half of the flap was scar-free.
  • CONCLUSIONS: Various strategies are available for autologous tissue breast reconstruction using a free TRAM flap in patients with a previous midline abdominal surgical scar.
  • [MeSH-major] Abdomen / surgery. Cicatrix. Mammaplasty. Surgical Flaps. Tissue and Organ Harvesting / methods

  • MedlinePlus Health Information. consumer health - Breast Reconstruction.
  • MedlinePlus Health Information. consumer health - Scars.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16141811.001).
  • [ISSN] 1529-4242
  • [Journal-full-title] Plastic and reconstructive surgery
  • [ISO-abbreviation] Plast. Reconstr. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


73. Lacz NL, Zurlo JV: Small bowel diverticulitis: an often overlooked cause of acute abdomen. Emerg Radiol; 2010 Nov;17(6):497-501
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Small bowel diverticulitis: an often overlooked cause of acute abdomen.
  • Though the final diagnosis was the same, each patient's symptomatology was different, mimicking more common pathologies.
  • Thus, it is important to consider this entity when confronted with signs and symptoms of acute abdomen, especially in the elderly.
  • A missed or delayed diagnosis can lead to costly erroneous studies, incorrect treatments and delay in proper management, resulting in significant morbidity and even mortality.
  • [MeSH-major] Abdomen, Acute / diagnostic imaging. Diverticulitis / diagnostic imaging. Intestine, Small. Tomography, X-Ray Computed


74. Ringbaek TJ, Krasnik M, Clementsen P, Skov BG, Rasmussen EN, Vilmann P: Transesophageal endoscopic ultrasound/fine-needle aspiration diagnosis of a malignant adrenal gland in a patient with non-small cell lung cancer and a negative CT scan. Lung Cancer; 2005 May;48(2):247-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transesophageal endoscopic ultrasound/fine-needle aspiration diagnosis of a malignant adrenal gland in a patient with non-small cell lung cancer and a negative CT scan.
  • Adrenal metastasis is only seen on CT scan is less than 5% of patients with otherwise resectable NSCLS, but this diagnosis has a major impact on treatment and prognosis.
  • Prospective studies are needed to assess the incremental yield of EUS/FNA over upper abdominal CT scan and PET for detecting left adrenal metastasis in patients with suspected or proven otherwise respectable NSCLC.
  • [MeSH-major] Adrenal Gland Neoplasms / diagnosis. Adrenal Gland Neoplasms / secondary. Carcinoma, Non-Small-Cell Lung / diagnosis. Carcinoma, Non-Small-Cell Lung / secondary. Lung Neoplasms / diagnosis. Lung Neoplasms / pathology


75. Cohen JK, Cai LQ, Zhu YS, La Perle KM: Pancreaticoduodenal arterial rupture and hemoabdomen in ACI/SegHsd rats with polyarteritis nodosa. Comp Med; 2007 Aug;57(4):370-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • ACII SegHsd rats were maintained on high-fat (40.5%), low-fat (11.6%), and high-fat to low-fat dietary protocols to examine the correlation between dietary fat and the regulation of prostate 5alpha-reductase gene expression and prostate cancer.
  • [MeSH-major] Abdominal Cavity / pathology. Arteries / pathology. Duodenal Diseases / pathology. Gastrointestinal Hemorrhage / pathology. Pancreatic Diseases / pathology. Polyarteritis Nodosa / pathology


76. Regge D, Neri E, Turini F, Chiara G: Role of CT colonography in inflammatory bowel disease. Eur J Radiol; 2009 Mar;69(3):404-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, investigating contemporarily the colon, other abdominal organs and the peritoneum with CTC is at times useful in patients with IBD, especially when other diagnostic tools fail.
  • Furthermore, since symptoms of colorectal cancer sometimes superimpose to those of inflammatory disease, it may happen to image patients with IBD incidentally.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19167180.001).
  • [ISSN] 1872-7727
  • [Journal-full-title] European journal of radiology
  • [ISO-abbreviation] Eur J Radiol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Ireland
  • [Number-of-references] 42
  •  go-up   go-down


77. Landrum LM, Gold MA, Moore KN, Myers TK, McMeekin DS, Walker JL: Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: a review of complications and completion rates. Gynecol Oncol; 2008 Feb;108(2):342-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: a review of complications and completion rates.
  • OBJECTIVE: Intraperitoneal (i.p.) chemotherapy has a clear survival advantage in patients with advanced ovarian cancer, but the high rate of complications has discouraged widespread acceptance.
  • Eleven patients (13%) discontinued treatment due to catheter-related complications including infection (n=4), access difficulties (n=3), grade 4 abdominal pain (n=1), port leaking (n=1), and development of a peritoneal-vaginal fistula (n=1).


78. Shao YF, Wu TC, Shan Y, Wu JX, Wang X, Zhao P: [Clinico-pathological characteristics of surgical effect on periampullary cancers: report of 631 cases]. Zhonghua Yi Xue Za Zhi; 2005 Mar 2;85(8):510-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinico-pathological characteristics of surgical effect on periampullary cancers: report of 631 cases].
  • OBJECTIVE: To analyze the differences and relationships among periampullary cancers.
  • METHODS: A retrospective study was accomplished on the clinical manifestation, pathological behavior and postoperative survival of 631 patients with periampullary cancer hospitalized from Jan 1980 to Dec 2003.
  • RESULTS: The characteristics of different periampullary cancers, in the order of carcinoma of head of pancreas (n = 352), carcinoma of common bile duct (n = 42), carcinoma of Vater's ampulla (n = 189), and duodenal cancer (n = 48) were as follows:.
  • (3) the mean tumor size was 6.0 +/- 2.2, 3.0 +/- 1.3, 3.0 +/- 1.9, and 4.8 +/- 3.9 cm respectively (chi(2) = 255.7, P < 0.01);.
  • Distant metastasis occurred in 98 cases, mostly to liver, abdominal cavity, and omentum.
  • Local invasion mainly occurred in duodenum (chi(2) = 10.76, P < 0.01), common bile duct (chi(2) = 15.16, P < 0.01), and periampullary tissues (chi(2) = 22.49, P < 0.01), and great vessels (chi(2) = 51.25, P < 0.01). (5) the T staging (chi(2) = 11.68, P < 0.01) and lymph node status (chi(2) = 8.33, P < 0.05) of the removed tumor specimens were different among different kinds of carcinomas;.
  • CONCLUSION: Different tumor has its predominant clinical manifestation, pathological character, the probability of resection, and postoperative median survival.
  • The prognosis after surgical treatment may be decided by biological behavior of tumor itself.

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15949327.001).
  • [ISSN] 0376-2491
  • [Journal-full-title] Zhonghua yi xue za zhi
  • [ISO-abbreviation] Zhonghua Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


79. Cánovas Ivorra JA, Castillo Gimeno JM, Burriel Ruiz C, Peláez Malagón S, Michelena Barcena J, Ramírez Daniel A: [Renal metastases of a squamous cell carcinoma of the lung. Case report and bibliographic review]. Arch Esp Urol; 2006 Jun;59(5):526-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Metástasis renal de carcinoma escamoso de pulmón. A propósito de un nuevo caso y revisión de la literatura.
  • RESULTS: Ultrasound showed a solid-cystic tumor in the lower pole of the kidney without hydronephrosis.
  • Abdominal-pelvic CT scan reported retroperitoneal adenopathies > 1 cm in the area of the aorta-cava and a 5 cm heterogeneous mass.
  • CONCLUSIONS: Renal metastatic lesions of patients with lung cancer present more frequently due to the higher accuracy of radiological tests and have, as well as the primary tumors, very poor survival rates.


80. Thompson WM: Gasless abdomen in the adult: what does it mean? AJR Am J Roentgenol; 2008 Oct;191(4):1093-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Gasless abdomen in the adult: what does it mean?
  • OBJECTIVE: The objective of this article is to illustrate the causes of a gasless abdomen in an adult.
  • CONCLUSION: The gasless abdomen in the adult is often interpreted as nonspecific, which does not provide useful information for the patient's physician.
  • There are at least six causes of the gasless abdomen in the adult.
  • A specific cause of the gasless abdomen can usually be made when the patient's history is known.
  • The most serious cause of the gasless abdomen is small-bowel obstruction with or without ischemia.
  • [MeSH-minor] Adolescent. Adult. Aged. Ascites / radiography. Colectomy / adverse effects. Diagnosis, Differential. Female. Gastroenteritis / radiography. Humans. Intestinal Obstruction / radiography. Ischemia / radiography. Male. Middle Aged. Radiography, Abdominal. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18806148.001).
  • [ISSN] 1546-3141
  • [Journal-full-title] AJR. American journal of roentgenology
  • [ISO-abbreviation] AJR Am J Roentgenol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gases
  •  go-up   go-down


81. Xing PY, Shi YK, Feng FY, Qin Y, Liu P: [Clinical characteristics and treatment of desmoplastic small round cell tumor]. Zhonghua Zhong Liu Za Zhi; 2010 Feb;32(2):139-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinical characteristics and treatment of desmoplastic small round cell tumor].
  • OBJECTIVE: To investigate the clinical characteristics and treatment of desmoplastic small round cell tumor.
  • RESULTS: The median age of all cases was 23 (1.5 - 66) years old at the time of diagnosis.
  • The most common presenting complaint was intra-abdominal mass or pain (77.4%).
  • In 46 patients (86.8%), the primary tumor was located in the abdomen or pelvis.
  • Complete tumor resection was significantly correlated with long survival.
  • The 1- and 3-year survival rates were 70.5% and 53.7% in patients treated with complete tumor resection compared to 37.2% and 4.8% in the incomplete tumor resection cohort (P = 0.0020).
  • CONCLUSION: Complete tumor resection results in improved survival in patients with DSRCT.
  • [MeSH-major] Abdominal Neoplasms / pathology. Abdominal Neoplasms / therapy. Desmoplastic Small Round Cell Tumor / pathology. Desmoplastic Small Round Cell Tumor / therapy
  • [MeSH-minor] Adolescent. Adult. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Bone Neoplasms / secondary. Combined Modality Therapy. Cyclophosphamide / therapeutic use. Doxorubicin / therapeutic use. Etoposide / therapeutic use. Female. Follow-Up Studies. Humans. Ifosfamide / therapeutic use. Liver Neoplasms / secondary. Lymph Node Excision. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Recurrence, Local. Prostatic Neoplasms / pathology. Prostatic Neoplasms / therapy. Radiotherapy, Conformal. Surgical Procedures, Operative. Survival Rate. Vincristine / therapeutic use. Young Adult

  • Genetic Alliance. consumer health - Desmoplastic Small Round Cell Tumor.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. ETOPOSIDE .
  • Hazardous Substances Data Bank. IFOSFAMIDE .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20403246.001).
  • [ISSN] 0253-3766
  • [Journal-full-title] Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • [ISO-abbreviation] Zhonghua Zhong Liu Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] China
  • [Chemical-registry-number] 5J49Q6B70F / Vincristine; 6PLQ3CP4P3 / Etoposide; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; UM20QQM95Y / Ifosfamide; IVAD protocol
  •  go-up   go-down


82. Rufo PA, Bousvaros A: Current therapy of inflammatory bowel disease in children. Paediatr Drugs; 2006;8(5):279-302
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ulcerative colitis (UC) and Crohn disease (CD) are chronic intestinal inflammatory diseases that can present as bloody diarrhea, abdominal pain, and malnutrition.
  • Because surgical treatment of CD is not curative, it is typically reserved for those patients either with persistent symptoms and disease limited to a small section of the intestine (e.g. the terminal ileum and cecum) or for the management of complications of the disease including stricture or abdominal abscess.
  • In addition, patients with UC and CD involving the colon are at increased risk of developing colon cancer, and should be enrolled into a colonoscopy surveillance program after 8-10 years of disease duration.
  • [MeSH-minor] Anti-Inflammatory Agents / therapeutic use. Child. Colitis, Ulcerative / diagnosis. Colitis, Ulcerative / epidemiology. Colitis, Ulcerative / physiopathology. Colitis, Ulcerative / therapy. Crohn Disease / diagnosis. Crohn Disease / epidemiology. Crohn Disease / physiopathology. Crohn Disease / therapy. Female. Gastrointestinal Agents / therapeutic use. Humans. Immunosuppressive Agents / therapeutic use. Nutrition Disorders / complications. Probiotics / therapeutic use

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lancet. 1996 Jan 27;347(8996):215-9 [8551879.001]
  • [Cites] Dis Colon Rectum. 1995 Jan;38(1):100-3 [7813336.001]
  • [Cites] Am J Gastroenterol. 2000 Nov;95(11):3189-94 [11095340.001]
  • [Cites] J Pediatr. 2003 Oct;143(4):525-31 [14571234.001]
  • [Cites] Arthritis Rheum. 1994 Mar;37(3):316-28 [8129787.001]
  • [Cites] Gastroenterology. 2002 Jan;122(1):72-7 [11781282.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 1989 May;8(4):528-32 [2566669.001]
  • [Cites] J Clin Invest. 1998 Mar 1;101(5):1163-74 [9486988.001]
  • [Cites] Lancet. 2004 May 29;363(9423):1802-11 [15172781.001]
  • [Cites] Inflamm Bowel Dis. 1996 Winter;2(4):229-35 [23282587.001]
  • [Cites] Aliment Pharmacol Ther. 2000 Feb;14 (2):171-6 [10651657.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 1993 Jul;17(1):32-8 [8102399.001]
  • [Cites] Gastroenterology. 2003 Oct;125(4):1025-31 [14517785.001]
  • [Cites] Gastroenterology. 2004 Sep;127(3):723-9 [15362027.001]
  • [Cites] Am J Gastroenterol. 2002 Dec;97(12):2962-72 [12492177.001]
  • [Cites] J Pediatr. 1991 Dec;119(6):994-7 [1960626.001]
  • [Cites] Lancet. 1994 May 21;343(8908):1249-52 [7910274.001]
  • [Cites] Aliment Pharmacol Ther. 2003 Jun 1;17(11):1365-9 [12786630.001]
  • [Cites] Inflamm Bowel Dis. 1999 May;5(2):119-33 [10338381.001]
  • [Cites] Ann Intern Med. 1984 Sep;101(3):377-86 [6147110.001]
  • [Cites] Eur J Gastroenterol Hepatol. 2004 Jan;16(1):47-54 [15095852.001]
  • [Cites] Lancet. 2002 May 4;359(9317):1541-9 [12047962.001]
  • [Cites] Gastroenterology. 1990 Apr;98(4):811-8 [2179031.001]
  • [Cites] Gastroenterology. 2003 May;124(5):1202-9 [12730861.001]
  • [Cites] Aliment Pharmacol Ther. 2002 Aug;16(8):1503-7 [12182750.001]
  • [Cites] Gastroenterol Clin Biol. 1980 Jan;4(1):19-25 [6989700.001]
  • [Cites] N Engl J Med. 1995 Feb 2;332(5):330-1 [7816071.001]
  • [Cites] Gastroenterology. 1979 Aug;77(2):272-9 [109347.001]
  • [Cites] Dis Colon Rectum. 1990 May;33(5):394-7 [1970284.001]
  • [Cites] Clin Infect Dis. 1999 Feb;28(2):299-308 [10064248.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2003 Feb;36(2):248-52 [12548062.001]
  • [Cites] Surgery. 1983 Jan;93(1 Pt 2):165-71 [6849201.001]
  • [Cites] Gastroenterology. 2000 Aug;119(2):305-9 [10930365.001]
  • [Cites] Gastroenterology. 1995 May;108(5):1427-33 [7729635.001]
  • [Cites] Am J Gastroenterol. 2000 May;95(5):1201-7 [10811328.001]
  • [Cites] Gastroenterology. 1977 Oct;73(4 Pt 1):828-32 [408222.001]
  • [Cites] Gastroenterology. 1997 Nov;113(5):1465-73 [9352848.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2000 Oct;31(4):453-7 [11045848.001]
  • [Cites] Aliment Pharmacol Ther. 2004 Dec;20(11-12):1329-36 [15606395.001]
  • [Cites] N Engl J Med. 2000 Jun 1;342(22):1627-32 [10833208.001]
  • [Cites] Am J Gastroenterol. 2003 Apr;98(4):833-8 [12738464.001]
  • [Cites] Inflamm Bowel Dis. 2004 Jul;10(4):481-3 [15475762.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2002 Mar;34(3):307-11 [11964959.001]
  • [Cites] Am J Gastroenterol. 1997 Jul;92(7):1143-7 [9219787.001]
  • [Cites] Int Arch Allergy Appl Immunol. 1977;54(5):422-7 [328408.001]
  • [Cites] Am J Gastroenterol. 2000 May;95(5):1139-46 [10811318.001]
  • [Cites] Aliment Pharmacol Ther. 1997 Oct;11(5):853-8 [9354192.001]
  • [Cites] Aliment Pharmacol Ther. 2002 Apr;16(4):699-705 [11929387.001]
  • [Cites] Inflamm Bowel Dis. 2002 Sep;8(5):317-24 [12479646.001]
  • [Cites] Gastroenterology. 2006 Feb;130(2):323-33; quiz 591 [16472588.001]
  • [Cites] J Clin Gastroenterol. 1997 Dec;25(4):653-8 [9451682.001]
  • [Cites] J Clin Invest. 1993 Dec;92(6):2675-82 [8254024.001]
  • [Cites] Aliment Pharmacol Ther. 2003 Oct 1;18(7):741-7 [14510748.001]
  • [Cites] Ann Intern Med. 1989 Oct 15;111(8):641-9 [2802419.001]
  • [Cites] Gastroenterology. 1979 Oct;77(4 Pt 2):907-13 [467942.001]
  • [Cites] Best Pract Res Clin Gastroenterol. 2003 Feb;17(1):63-73 [12617883.001]
  • [Cites] Am J Gastroenterol. 2002 Apr;97(4):803-23 [12003413.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 1993 Apr;16(3):337-9 [8492268.001]
  • [Cites] Scand J Gastroenterol. 1976;11(7):651-6 [11545.001]
  • [Cites] Gastroenterology. 1999 Dec;117(6):1278-87 [10579968.001]
  • [Cites] Aliment Pharmacol Ther. 1999 Sep;13 Suppl 4:23-8; discussion 38 [10597336.001]
  • [Cites] J Pediatr. 1990 Nov;117(5):809-14 [2231216.001]
  • [Cites] Aliment Pharmacol Ther. 2004 Jul 15;20(2):167-72 [15233696.001]
  • [Cites] Inflamm Bowel Dis. 2001 Nov;7(4):301-5 [11720319.001]
  • [Cites] Inflamm Bowel Dis. 2005 Sep;11(9):833-9 [16116318.001]
  • [Cites] Gastroenterology. 1999 Dec;117(6):1271-7 [10579967.001]
  • [Cites] Am J Gastroenterol. 1996 May;91(5):927-34 [8633583.001]
  • [Cites] Ann N Y Acad Sci. 1998 Nov 17;859:315-8 [9928412.001]
  • [Cites] Am J Gastroenterol. 1997 Feb;92(2):204-11 [9040192.001]
  • [Cites] Gut. 2006 Sep;55(9):1255-62 [16484504.001]
  • [Cites] J Pediatr. 2002 Jan;140(1):75-80 [11815767.001]
  • [Cites] Gastroenterology. 1998 Jan;114(1):15-22 [9428213.001]
  • [Cites] Am J Gastroenterol. 1999 Mar;94(3):674-8 [10086650.001]
  • [Cites] Gastroenterology. 1994 Jun;106(6):1429-35 [8194687.001]
  • [Cites] Am J Gastroenterol. 1989 Mar;84(3):249-54 [2919581.001]
  • [Cites] Inflamm Bowel Dis. 1997 Summer;3(2):65-78 [23282747.001]
  • [Cites] Gut. 2000 Oct;47(4):506-13 [10986210.001]
  • [Cites] Am J Gastroenterol. 2000 Jul;95(7):1730-4 [10925976.001]
  • [Cites] J Clin Gastroenterol. 1993 Apr;16(3):215-8 [8099363.001]
  • [Cites] Gastroenterology. 2001 Aug;121(2):268-74 [11487536.001]
  • [Cites] Gastroenterology. 2000 May;118(5):859-66 [10784585.001]
  • [Cites] Rev Gastroenterol Disord. 2003;3 Suppl 1:S30-8 [12684587.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 1982;1(4):541-6 [6136578.001]
  • [Cites] Gut. 1996 Feb;38(2):229-33 [8801202.001]
  • [Cites] Inflamm Bowel Dis. 2002 Jan;8(1):1-9 [11837932.001]
  • [Cites] N Engl J Med. 2005 Dec 8;353(23):2462-76 [16339095.001]
  • [Cites] Scand J Gastroenterol. 1987 Oct;22(8):987-92 [3317784.001]
  • [Cites] Inflamm Bowel Dis. 1998 Nov;4(4):276-9 [9836079.001]
  • [Cites] Gastroenterology. 1997 May;112(5):1475-81 [9136824.001]
  • [Cites] J Biol Chem. 2003 Oct 24;278(43):41702-8 [12871942.001]
  • [Cites] Dig Liver Dis. 2002 Sep;34 Suppl 2:S63-5 [12408443.001]
  • [Cites] Gut. 1987 Feb;28(2):190-5 [2881849.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2000 Jul;31(1):3-5 [10896063.001]
  • [Cites] Gut. 1995 Nov;37(5):674-8 [8549944.001]
  • [Cites] Gut. 1998 Apr;42(4):477-84 [9616307.001]
  • [Cites] Aliment Pharmacol Ther. 1994 Feb;8(1):35-43 [8186345.001]
  • [Cites] Aliment Pharmacol Ther. 2003 Dec;18(11-12):1113-20 [14653831.001]
  • [Cites] Gastroenterology. 1998 Oct;115(4):813-21 [9753482.001]
  • [Cites] J Child Neurol. 2001 Jun;16(6):458-61 [11417618.001]
  • [Cites] Aliment Pharmacol Ther. 2003 Jan;17(1):85-92 [12492736.001]
  • [Cites] Am J Gastroenterol. 2002 Apr;97(4):928-32 [12003428.001]
  • [Cites] Gastroenterology. 2001 Nov;121(5):1145-57 [11677207.001]
  • [Cites] Aliment Pharmacol Ther. 1995 Jun;9(3):293-300 [7654892.001]
  • [Cites] Aliment Pharmacol Ther. 2003 Jul 1;18(1):65-75 [12848627.001]
  • [Cites] Gastroenterology. 2000 Apr;118(4):705-13 [10734022.001]
  • [Cites] Aliment Pharmacol Ther. 2003 Jan;17(1):75-84 [12492735.001]
  • [Cites] Lancet. 1999 Aug 21;354(9179):635-9 [10466665.001]
  • [Cites] Ann Intern Med. 1980 Oct;93(4):585-7 [7436193.001]
  • [Cites] Gut. 1977 Aug;18(8):680-1 [330354.001]
  • [Cites] Gastroenterology. 2001 May;120(6):1541-3 [11313325.001]
  • [Cites] Am J Gastroenterol. 2000 Oct;95(10):3002-3 [11051400.001]
  • [Cites] J Pediatr. 2000 Dec;137(6):794-9 [11113835.001]
  • [Cites] N Engl J Med. 1995 Feb 2;332(5):292-7 [7816064.001]
  • [Cites] Scand J Gastroenterol Suppl. 1999;230:106-10 [10499470.001]
  • [Cites] Am J Gastroenterol. 2003 Feb;98(2):369-76 [12591057.001]
  • [Cites] J Clin Gastroenterol. 1987 Aug;9(4):415-7 [2888801.001]
  • [Cites] Gastroenterology. 1990 Oct;99(4):956-63 [2394349.001]
  • [Cites] Clin Infect Dis. 2003 Jun 1;36(11):1404-10 [12766835.001]
  • [Cites] Aliment Pharmacol Ther. 1999 Aug;13(8):1103-8 [10468688.001]
  • [Cites] Br J Clin Pharmacol. 1995 Apr;39(4):456-9 [7640156.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2000 Jul;31(1):8-15 [10896064.001]
  • [Cites] Am J Gastroenterol. 1997 Dec;92(12):2203-9 [9399753.001]
  • [Cites] Gastroenterology. 1998 Sep;115(3):525-32 [9721148.001]
  • [Cites] Lancet. 1990 Jul 7;336(8706):16-9 [1973211.001]
  • [Cites] Aliment Pharmacol Ther. 2001 Feb;15(2):251-6 [11148445.001]
  • [Cites] J Clin Gastroenterol. 2000 Apr;30(3):294-8 [10777191.001]
  • [Cites] Mayo Clin Proc. 1994 May;69(5):409-15 [8170189.001]
  • [Cites] Dis Colon Rectum. 1995 May;38(5):474-9 [7736877.001]
  • [Cites] J Pediatr. 1998 May;132(5):830-5 [9602195.001]
  • [Cites] Mayo Clin Proc. 1991 Dec;66(12):1270-80 [1749296.001]
  • [Cites] Gastroenterology. 2000 Jun;118(6):1018-24 [10833475.001]
  • [Cites] Gastroenterology. 1998 Jul;115(1):182-205 [9649475.001]
  • [Cites] N Engl J Med. 1999 May 6;340(18):1398-405 [10228190.001]
  • [Cites] Inflamm Bowel Dis. 2001 May;7 Suppl 1:S23-9 [11380040.001]
  • [Cites] Inflamm Bowel Dis. 2002 Jan;8(1):10-5 [11837933.001]
  • [Cites] Gastroenterology. 1993 May;104(5):1293-301 [8482443.001]
  • [Cites] Drugs. 2002;62(15):2263-82 [12381231.001]
  • [Cites] N Engl J Med. 1994 Jun 30;330(26):1841-5 [8196726.001]
  • [Cites] Gastroenterology. 1996 May;110(5):1416-21 [8613046.001]
  • [Cites] Hum Mol Genet. 2004 Apr 1;13 Spec No 1:R161-8 [14764625.001]
  • [Cites] Gastroenterology. 1999 Jul;117(1):282-3 [10428613.001]
  • [Cites] Gastroenterology. 2000 Oct;119(4):895-902 [11040176.001]
  • [Cites] Gastroenterology. 2001 May;120(6):1323-9 [11313301.001]
  • [Cites] Gut. 1997 Jun;40(6):775-81 [9245932.001]
  • [Cites] Pharm World Sci. 2001 Feb;23(1):17-21 [11344586.001]
  • [Cites] Gastroenterology. 1995 Apr;108(4):1056-67 [7698572.001]
  • [Cites] Aliment Pharmacol Ther. 1997 Dec;11(6):1047-52 [9663828.001]
  • [Cites] Am J Gastroenterol. 2002 Dec;97(12):3078-86 [12492193.001]
  • [Cites] Aliment Pharmacol Ther. 2003 May 15;17(10):1273-81 [12755840.001]
  • [Cites] Minerva Med. 1980 Jan 21;71(2):103-10 [7354928.001]
  • [Cites] Gastroenterology. 1990 Nov;99(5):1347-51 [1976562.001]
  • [Cites] Dig Dis Sci. 1985 Jan;30(1):58-64 [2856904.001]
  • [Cites] Gastroenterology. 1988 Apr;94(4):1075-9 [3278942.001]
  • [Cites] Scand J Infect Dis Suppl. 1981;26:68-71 [6941458.001]
  • [Cites] Inflamm Bowel Dis. 1998 May;4(2):113-4; discussion 114-6 [9687218.001]
  • [Cites] Gastroenterology. 2004 Sep;127(3):730-40 [15362028.001]
  • [Cites] Gut. 2002 Oct;51(4):536-9 [12235076.001]
  • [Cites] Isr Med Assoc J. 2000 Aug;2(8):588-91 [10979350.001]
  • [Cites] J Clin Gastroenterol. 2000 Jul;31(1):60-2 [10914779.001]
  • [Cites] N Engl J Med. 2003 Jan 2;348(1):24-32 [12510039.001]
  • [Cites] Dis Colon Rectum. 2002 Sep;45(9):1200-5 [12352237.001]
  • [Cites] Cochrane Database Syst Rev. 2002;(4):CD000544 [12519547.001]
  • [Cites] JPEN J Parenter Enteral Nutr. 1982 May-Jun;6(3):194-9 [6809974.001]
  • [Cites] Z Gastroenterol. 2003 May;41(5):478-9 [16279009.001]
  • [Cites] Inflamm Bowel Dis. 2003 Jan;9(1):34-58 [12656136.001]
  • [Cites] Am J Gastroenterol. 2000 Aug;95(8):2000-8 [10950049.001]
  • [Cites] Am J Gastroenterol. 2003 Nov;98(11):2372-82 [14638336.001]
  • [Cites] Expert Opin Investig Drugs. 2003 Jul;12(7):1087-95 [12831345.001]
  • [Cites] J Clin Gastroenterol. 1989 Aug;11(4):392-5 [2569488.001]
  • [Cites] Dig Dis Sci. 1996 Dec;41(12):2471-6 [9011460.001]
  • [Cites] Am J Gastroenterol. 1994 May;89(5):692-8 [8172139.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):279-84 [14973103.001]
  • [Cites] Aust N Z J Med. 1998 Apr;28(2):179-83 [9612525.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2001 Jul;33(1):75-80 [11479412.001]
  • [Cites] Am J Gastroenterol. 2003 Jun;98(6):1309-14 [12818275.001]
  • [Cites] J Gastroenterol Hepatol. 2002 Feb;17(2):135-9 [11966942.001]
  • [Cites] Am J Gastroenterol. 1999 Jun;94(6):1587-92 [10364029.001]
  • [Cites] Rev Infect Dis. 1991 Nov-Dec;13(6):1213-5 [1775854.001]
  • [Cites] Free Radic Biol Med. 1996;21(3):367-73 [8855448.001]
  • [Cites] Inflamm Bowel Dis. 2004 Jul;10(4):333-8 [15475739.001]
  • [Cites] Gut. 1998 Mar;42(3):309-11 [9577327.001]
  • [Cites] Gastroenterology. 1995 Jun;108(6):1617-21 [7768364.001]
  • [Cites] Am J Gastroenterol. 1990 Sep;85(9):1079-82 [2202199.001]
  • [Cites] Gastroenterology. 1982 Aug;83(2):383-7 [7084615.001]
  • [Cites] Aliment Pharmacol Ther. 1989 Dec;3(6):597-603 [2577501.001]
  • [Cites] Drug Saf. 2000 Jun;22(6):479-85 [10877041.001]
  • [Cites] Immunol Today. 1992 Apr;13(4):136-42 [1374612.001]
  • [Cites] Hepatogastroenterology. 2000 Jan-Feb;47(31):71-82 [10690587.001]
  • [Cites] Scand J Gastroenterol. 1981;16(4):569-75 [6119763.001]
  • [Cites] Neurology. 1999 Aug 11;53(3):466-72 [10449105.001]
  • [Cites] Curr Opin Pediatr. 1995 Jun;7(3):323-7 [7663621.001]
  • [Cites] N Engl J Med. 2004 Feb 26;350(9):876-85 [14985485.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2004 Aug;39(2):166-70 [15269622.001]
  • [Cites] Dig Dis Sci. 1994 Feb;39(2):374-80 [8313821.001]
  • [Cites] Am J Gastroenterol. 2002 Feb;97(2):360-9 [11866274.001]
  • [Cites] Am J Gastroenterol. 1996 Sep;91(9):1711-4 [8792685.001]
  • [Cites] Gut. 1996 Apr;38(4):543-8 [8707085.001]
  • [Cites] Hepatogastroenterology. 1999 May-Jun;46(27):1724-9 [10430331.001]
  • [Cites] Gastroenterology. 2004 May;126(6):1620-33 [15168372.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 1999 Jan;28(1):54-8 [9890469.001]
  • [Cites] Gastroenterology. 1982 Sep;83(3):550-62 [6124474.001]
  • [Cites] Clin Gastroenterol Hepatol. 2006 May;4(5):621-30 [16678077.001]
  • [Cites] N Engl J Med. 1995 Jan 12;332(2):127 [7990899.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 1996 Oct;23(3):329-33 [8890089.001]
  • [Cites] Aliment Pharmacol Ther. 2003 Aug 15;18(4):415-23 [12940927.001]
  • [Cites] Dis Colon Rectum. 1986 Aug;29(8):495-502 [3731965.001]
  • [Cites] P R Health Sci J. 2000 Dec;19(4):329-33 [11293884.001]
  • [Cites] Dig Dis Sci. 1989 Dec;34(12):1841-54 [2598752.001]
  • (PMID = 17037946.001).
  • [ISSN] 1174-5878
  • [Journal-full-title] Paediatric drugs
  • [ISO-abbreviation] Paediatr Drugs
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Anti-Inflammatory Agents; 0 / Gastrointestinal Agents; 0 / Immunosuppressive Agents
  • [Number-of-references] 221
  •  go-up   go-down


83. Mullen JT, Davenport DL, Hutter MM, Hosokawa PW, Henderson WG, Khuri SF, Moorman DW: Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery. Ann Surg Oncol; 2008 Aug;15(8):2164-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery.
  • We sought to determine the impact of body mass index (BMI) on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery.
  • METHODS: A prospective, multi-institutional, risk-adjusted cohort study of patients undergoing major intra-abdominal cancer surgery was performed from the 14 university hospitals participating in the Patient Safety in Surgery Study of the National Surgical Quality Improvement Program (NSQIP).
  • Patients were stratified by National Institutes of Health (NIH)-defined BMI obesity class, with 573 (25.4%) patients classified as obese (BMI > 30 kg/m(2)).
  • CONCLUSION: In patients undergoing major intra-abdominal cancer surgery, obesity is not a risk factor for postoperative mortality or major complications.

  • MedlinePlus Health Information. consumer health - Obesity.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18548313.001).
  • [ISSN] 1534-4681
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


84. Anagrelide: new drug. Essential thrombocythaemia: further evaluation needed for this last-resort treatment. Prescrire Int; 2006 Jun;15(83):83-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It may also increase the risk of progression to cancer. (2) Anagrelide, initially studied as an antiplatelet drug, was approved in Europe for the treatment of essential thrombocythaemia in high-risk patients when other treatments fail or are poorly tolerated. (3) Evaluation data includes a trial versus hydroxycarbamide that was prematurely halted because of an excess of cardiovascular events among patients on anagrelide.
  • Gastrointestinal disturbances are also frequent (diarrhoea, nausea, abdominal pain, pancreatitis).
  • Some of these adverse effects can be fatal. (6) Follow-up is too short to show whether anagrelide affects the risk of progression to cancer. (7) In practice, anagrelide has a less favourable risk-benefit balance than hydroxycarbamide, which remains the first-line cytotoxic agent in this setting.

  • Hazardous Substances Data Bank. HYDROXYUREA .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16764090.001).
  • [ISSN] 1167-7422
  • [Journal-full-title] Prescrire international
  • [ISO-abbreviation] Prescrire Int
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Drugs, Investigational; 0 / Platelet Aggregation Inhibitors; 0 / Quinazolines; 0 / Vasodilator Agents; X6Q56QN5QC / Hydroxyurea
  •  go-up   go-down


85. Ruffato A, Mattioli S, Pileri S, Daddi N, D'Ovidio F, Pilotti V, Tazzari P: Do bone marrow isolated tumor cells influence long-term survival of non-small cell lung cancer? Eur J Cardiothorac Surg; 2009 Mar;35(3):463-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Do bone marrow isolated tumor cells influence long-term survival of non-small cell lung cancer?
  • INTRODUCTION: Inconsistent information on the prognostic significance of non-small cell lung cancer (NSCLC) isolated tumor cells (ITC) has been reported to date.
  • We sought to evaluate the survival for NSCLC in a group of patients in which the presence of bone marrow isolated tumor cells and their DNA ploidy was assessed.
  • Patient follow-up was with chest X-ray and abdominal US every 6 months, and CT-PET scan every 12 months for at least 5 years after surgery.
  • The median follow-up was 61 months, 21 patients died from causes unrelated to NSCLC and 12 patients died from causes related to tumor relapse.
  • [MeSH-minor] Aged. Aged, 80 and over. Female. Humans. Immunohistochemistry. Lymph Nodes / pathology. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Staging. Ploidies. Prognosis. Survival Analysis. Tumor Cells, Cultured


86. Oxentenko AS, Vierkant RA, Pardi DS, Farley DR, Dozois EJ, Hartman TE, Hough DM, Petersen WO, Klabunde CN, Sharpe K, Bond JH, Smith RA, Levin B, Pope JB, Schroy PC, Limburg PJ: Colorectal cancer screening perceptions and practices: results from a national survey of gastroenterology, surgery and radiology trainees. J Cancer Educ; 2007;22(4):219-26
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Colorectal cancer screening perceptions and practices: results from a national survey of gastroenterology, surgery and radiology trainees.
  • BACKGROUND: Colorectal cancer (CRC) screening in the United States is suboptimal.
  • We conducted a national survey to learn about CRC screening perceptions and practices among trainees who perform CRC screening tests including those enrolled in Gastroenterology and Hepatology (GIH), General and Colorectal Surgery, and Diagnostic and Abdominal Radiology training programs.
  • [MeSH-major] Colorectal Neoplasms / diagnosis. Gastroenterology / education. General Surgery / education. Internship and Residency. Mass Screening. Perception. Practice Patterns, Physicians'. Radiology / education

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gastroenterology. 2006 May;130(6):1872-85 [16697750.001]
  • [Cites] Fam Pract. 2003 Oct;20(5):545-51 [14507796.001]
  • [Cites] CA Cancer J Clin. 2002 Jan-Feb;52(1):8-22 [11814067.001]
  • [Cites] Am J Gastroenterol. 2002 Dec;97(12):3186-94 [12492209.001]
  • [Cites] Gerontologist. 2001 Dec;41(6):799-804 [11723348.001]
  • [Cites] Dig Dis Sci. 1997 Jun;42(6):1176-8 [9201080.001]
  • [Cites] Ann Intern Med. 2005 Jan 18;142(2):86-94 [15657156.001]
  • [Cites] Cancer Causes Control. 2005 Aug;16(6):735-42 [16049812.001]
  • [Cites] Dig Dis Sci. 2005 May;50(5):809-14 [15906749.001]
  • [Cites] J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):41-6 [16706810.001]
  • [Cites] Am J Gastroenterol. 2000 Dec;95(12):3629-32 [11151904.001]
  • [Cites] Ann Intern Med. 2004 Aug 17;141(4):264-71 [15313742.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2006 Mar 24;55(11):308-11 [16557215.001]
  • [Cites] Clin Gastroenterol Hepatol. 2004 Sep;2(9):813-9 [15354282.001]
  • [Cites] J Natl Cancer Inst. 1997 Oct 1;89(19):1406-22 [9326910.001]
  • [Cites] CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30 [16514137.001]
  • [Cites] Am J Gastroenterol. 2000 Aug;95(8):2068-73 [10950059.001]
  • [Cites] Bratisl Lek Listy. 2005;106(10):318-23 [16541612.001]
  • [Cites] Pediatrics. 2003 Apr;111(4 Pt 1):e299-303 [12671142.001]
  • [Cites] J Med Internet Res. 2004 Oct 29;6(4):e39 [15631963.001]
  • [Cites] Med Care. 2005 Sep;43(9):939-44 [16116360.001]
  • [Cites] Can J Anaesth. 2004 May;51(5):449-54 [15128630.001]
  • [Cites] Prev Med. 2004 May;38(5):536-50 [15066356.001]
  • [Cites] Gastroenterology. 2006 May;130(6):1865-71 [16697749.001]
  • [Cites] Fam Med. 2005 May;37(5):341-7 [15883900.001]
  • [Cites] Colorectal Dis. 2006 Sep;8(7):612-4 [16919116.001]
  • [Cites] Med Care. 2006 Feb;44(2):167-74 [16434916.001]
  • [Cites] J Natl Med Assoc. 2003 Sep;95(9):806-12 [14527047.001]
  • [Cites] Gastroenterology. 2003 Feb;124(2):544-60 [12557158.001]
  • [Cites] Ann Intern Med. 2002 Jul 16;137(2):129-31 [12118971.001]
  • [Cites] Am J Gastroenterol. 2005 Mar;100(3):677-84 [15743368.001]
  • [Cites] Prev Med. 2003 Dec;37(6 Pt 1):627-34 [14636796.001]
  • [Cites] World J Gastroenterol. 2006 Aug 28;12(32):5201-4 [16937533.001]
  • [Cites] J Health Commun. 2006;11 Suppl 1:71-92 [16641075.001]
  • [Cites] Am J Gastroenterol. 2003 Jun;98(6):1410-6 [12818289.001]
  • (PMID = 18067433.001).
  • [ISSN] 0885-8195
  • [Journal-full-title] Journal of cancer education : the official journal of the American Association for Cancer Education
  • [ISO-abbreviation] J Cancer Educ
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


87. Inoue Y, Kiryu S, Watanabe M, Oyaizu N, Ohtomo K: Fluorescence lymph node mapping in living mice using quantum dots and a compression technique. J Fluoresc; 2010 Mar;20(2):599-606
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We investigated non-invasive fluorescence lymph node mapping in mice with special reference to the assessment of deep abdominal lymph nodes.
  • Visualization of abdominal lymph nodes was compared with and without compression of the abdomen with transparent, colorless tape at injection doses of 1, 5, and 20 pmol.
  • Compression of the abdomen markedly improved the visualization of the iliac nodes, which were invisible at 5 pmol without compression and visible at 1 pmol with compression.
  • Fluorescence lymph node mapping using quantum dots allowed the visualization of deep abdominal lymph nodes in addition to superficial nodes in intact mice, with the aid of a simple compression technique.
  • [MeSH-minor] Abdomen / anatomy & histology. Absorption. Animals. Diet. Female. Mice. Mice, Inbred BALB C. Scattering, Radiation. Time Factors

  • MedlinePlus Health Information. consumer health - Diagnostic Imaging.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nat Biotechnol. 2004 Jan;22(1):93-7 [14661026.001]
  • [Cites] Nat Biotechnol. 2001 Apr;19(4):316-7 [11283581.001]
  • [Cites] Ann Surg Oncol. 2006 Dec;13(12):1671-81 [17009138.001]
  • [Cites] J Biomed Opt. 2005 Jul-Aug;10(4):41207 [16178631.001]
  • [Cites] BMC Cancer. 2008 Apr 22;8:111 [18430208.001]
  • [Cites] Nat Mater. 2005 Jun;4(6):435-46 [15928695.001]
  • [Cites] J Immunol Methods. 2008 Mar 20;332(1-2):170-4 [18164026.001]
  • [Cites] Mol Imaging. 2008 Jan-Feb;7(1):21-7 [18384720.001]
  • [Cites] Trends Cell Biol. 2004 Sep;14(9):497-504 [15350978.001]
  • [Cites] J Anat. 1986 Oct;148:25-46 [3693091.001]
  • [Cites] Nano Lett. 2007 Jun;7(6):1711-6 [17530812.001]
  • [Cites] Methods Mol Biol. 2007;374:147-59 [17237537.001]
  • [Cites] Breast Cancer Res Treat. 2007 May;103(1):23-8 [17028977.001]
  • [Cites] Methods Mol Biol. 2005;303:1-17 [15923671.001]
  • [Cites] Bioconjug Chem. 2007 Mar-Apr;18(2):389-96 [17263568.001]
  • [Cites] Eur Radiol. 2003 Jan;13(1):195-208 [12541130.001]
  • (PMID = 20082211.001).
  • [ISSN] 1573-4994
  • [Journal-full-title] Journal of fluorescence
  • [ISO-abbreviation] J Fluoresc
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  •  go-up   go-down


88. Pocard M, Benoist S: [Cancer of the rectum with unresectable metastases]. J Chir (Paris); 2005 Sep-Oct;142(5):313-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Cancer of the rectum with unresectable metastases].
  • [Transliterated title] Un cancer du rectum avec métastases non résécables.
  • [MeSH-minor] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Biopsy. Colonoscopy. Combined Modality Therapy. Endosonography. Hepatectomy. Humans. Male. Middle Aged. Palliative Care. Prognosis. Radiography, Abdominal. Radiography, Thoracic. Radiotherapy Dosage. Time Factors. Tomography, X-Ray Computed. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16292212.001).
  • [ISSN] 0021-7697
  • [Journal-full-title] Journal de chirurgie
  • [ISO-abbreviation] J Chir (Paris)
  • [Language] fre
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] France
  •  go-up   go-down


89. Landolsi A, Chabchoub I, Limem S, Gharbi O, Chaafai R, Hochlef M, Fatma LB, Trimech M, Krifa A, Ajmi S, Mokni M, Hadj Hmida MB, Ahmed SB: [Primary digestive tract lymphoma in central region of Tunisia: anatomoclinical study and therapeutic results about 153 cases]. Bull Cancer; 2010 Apr;97(4):435-43
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Les lymphomes primitifs du tube digestif (LPTD) dans le centre tunisien: étude anatomoclinique et résultats thérapeutiques à propos de 153 cas.
  • Their clinical and histological presentations are heterogeneous depending on the site of the lesion.
  • Tumor sites were gastric (67%), intestinal (26%) and gastrointestinal (7%).
  • Abdominal pain (87%) followed by vomiting and diarrhoea (37 and 15%) were the most common symptoms.
  • Only 46% of patients had surgery (14 for surgical complication, 6 for residual tumor after chemotherapy and 22 to have histological diagnosis).
  • We conclude that stomach is the main site of PGIL in our region, intestinal lymphoma is less frequent and IPSID has become rare.
  • [MeSH-minor] Abdominal Pain / etiology. Adolescent. Adult. Aged. Aged, 80 and over. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Diarrhea / etiology. Female. Humans. Male. Middle Aged. Prognosis. Retrospective Studies. Tunisia. Vomiting / etiology. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20395189.001).
  • [ISSN] 1769-6917
  • [Journal-full-title] Bulletin du cancer
  • [ISO-abbreviation] Bull Cancer
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


90. Yoshikawa T, Omura K, Kobayashi O, Nashimoto A, Takabayashi A, Yamada T, Yamaue H, Fujii M, Yamaguchi T, Nakajima T: A phase II study of preoperative chemotherapy with S-1 plus cisplatin followed by D2/D3 gastrectomy for clinically serosa-positive gastric cancer (JACCRO GC-01 study). Eur J Surg Oncol; 2010 Jun;36(6):546-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A phase II study of preoperative chemotherapy with S-1 plus cisplatin followed by D2/D3 gastrectomy for clinically serosa-positive gastric cancer (JACCRO GC-01 study).
  • AIMS: Clinically serosa-positive (T3-4) gastric cancer has a poor prognosis.
  • This phase II trial explored the feasibility and safety of preoperative chemotherapy followed by D2 or D3 gastrectomy in this type of gastric cancer.
  • METHODS: Patients with T3-4 gastric cancer received one course of S-1 (80mg/m(2) daily for 3 weeks) and cisplatin (60mg/m(2) on day 8) chemotherapy and then underwent D2 or D3 gastrectomy with curative intent.
  • Operative morbidity occurred in 5 of 49 patients, including pancreatic fistula in 1 and abdominal abscess in 2.
  • CONCLUSION: This multi-modality treatment seems to be feasible and safe for T3-4 gastric cancer.
  • [MeSH-minor] Adult. Aged. Cisplatin / administration & dosage. Combined Modality Therapy. Drug Combinations. Female. Humans. Male. Middle Aged. Neoplasm Staging. Oxonic Acid / administration & dosage. Preoperative Care. Tegafur / administration & dosage. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20541062.001).
  • [ISSN] 1532-2157
  • [Journal-full-title] European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • [ISO-abbreviation] Eur J Surg Oncol
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Drug Combinations; 150863-82-4 / S 1 (combination); 1548R74NSZ / Tegafur; 5VT6420TIG / Oxonic Acid; Q20Q21Q62J / Cisplatin
  •  go-up   go-down


91. Lee SW, Lee TY, Yeh HZ, Chang CS, Wang RC: An unusual case of metastatic small intestinal tumor due to prostate cancer. J Chin Med Assoc; 2009 May;72(5):271-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An unusual case of metastatic small intestinal tumor due to prostate cancer.
  • Prostate cancer is a common cancer in men, and its clinical behavior ranges from microscopic tumors to aggressive cancer with metastatic potential.
  • We report the case of an 81-year-old man with primary prostate cancer, AJCC stage T2 and Gleason's score 10, which was diagnosed in March 2007.
  • The patient received upper endoscopy due to symptoms of abdominal fullness and body weight loss, and a soft tumor in the secondary portion of the duodenum was found.
  • The pathologic appearance was consistent with prostate cancer metastatic to the small bowel.
  • Abdominal computed tomography also showed multiple liver tumors with enlarged retroperitoneal lymph nodes.
  • This case should help raise clinical awareness of the possibility of unusual metastatic sites in patients with primary prostate cancer.


92. Trikudanathan G, Dasanu CA: Adenosquamous carcinoma of the pancreas: a distinct clinicopathologic entity. South Med J; 2010 Sep;103(9):903-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although such features as central necrosis and hypervascularity are suggestive of pancreatic ASC, more research is necessary to identify other, more specific markers for this tumor subtype.
  • Humoral hypercalcemia of malignancy has also been described with ASC of the pancreas, likely as a result of PTHrP production by the squamous component of the tumor.
  • Both pathologic and molecular features of pancreatic ASC characterize it as a distinct subtype of pancreatic cancer.
  • [MeSH-major] Carcinoma, Adenosquamous / diagnosis. Carcinoma, Adenosquamous / therapy. Pancreatic Neoplasms / diagnosis. Pancreatic Neoplasms / therapy
  • [MeSH-minor] Abdominal Pain / etiology. Biomarkers, Tumor. Chemotherapy, Adjuvant. Diagnostic Imaging. Genetic Predisposition to Disease. Humans. Jaundice / etiology. Mutation. Necrosis. Palliative Care. Pancreas / pathology. Pancreatectomy. Risk Factors. Survival Analysis. Weight Loss

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20697320.001).
  • [ISSN] 1541-8243
  • [Journal-full-title] Southern medical journal
  • [ISO-abbreviation] South. Med. J.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Number-of-references] 43
  •  go-up   go-down


93. Morisawa N, Koyama T, Togashi K: Metastatic lymph nodes in urogenital cancers: contribution of imaging findings. Abdom Imaging; 2006 Sep-Oct;31(5):620-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastatic lymph nodes in urogenital cancers: contribution of imaging findings.
  • The clinical significance of a radiologic recognition of enlarged nodes also differs by cancer type in relation to differences in staging systems and treatment.
  • The presence of regional lymphadenopathy in patients with renal cell carcinoma often alters surgical methods, whereas the presence of regional lymphadenopathy is an indication of systemic chemotherapy in patients with cancers of the urinary tract, prostate, and testicles.
  • In this report, preferential sites and staging of nodal metastasis and contributions of radiologic imaging are reviewed for each urogenital cancer.
  • [MeSH-major] Lymphatic Metastasis / diagnosis. Magnetic Resonance Imaging. Tomography, X-Ray Computed. Urogenital Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17131207.001).
  • [ISSN] 0942-8925
  • [Journal-full-title] Abdominal imaging
  • [ISO-abbreviation] Abdom Imaging
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 45
  •  go-up   go-down


94. Whittaker CS, Coady A, Culver L, Rustin G, Padwick M, Padhani AR: Diffusion-weighted MR imaging of female pelvic tumors: a pictorial review. Radiographics; 2009 May-Jun;29(3):759-74; discussion 774-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Functional imaging is becoming increasingly important in the evaluation of cancer patients because of the limitations of morphologic imaging, particularly in the assessment of response to therapy.
  • Diffusion-weighted magnetic resonance (MR) imaging has been established as a useful functional imaging tool in neurologic applications for a number of years, but recent technical advances now allow its use in abdominal and pelvic applications.
  • In addition, this unique noninvasive modality has demonstrated the capacity to help discriminate between benign and malignant uterine lesions and to help assess the extent of peritoneal spread from gynecologic malignancies.
  • [MeSH-minor] Aged. Aged, 80 and over. Endometrial Neoplasms / pathology. Female. Humans. Leiomyoma / pathology. Lymphatic Metastasis. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19448114.001).
  • [ISSN] 1527-1323
  • [Journal-full-title] Radiographics : a review publication of the Radiological Society of North America, Inc
  • [ISO-abbreviation] Radiographics
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 22
  •  go-up   go-down


95. Kuester D, Dalicho S, Mönkemüller K, Benedix F, Lippert H, Guenther T, Roessner A, Meyer F: Synchronous multifocal colorectal carcinoma in a patient with delayed diagnosis of ulcerative pancolitis. Pathol Res Pract; 2008;204(12):905-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Synchronous multifocal colorectal carcinoma in a patient with delayed diagnosis of ulcerative pancolitis.
  • Patients with ulcerative colitis face an increased lifetime risk of developing colorectal cancer.
  • A 36-year-old male presented with symptoms of persisting abdominal pain that had lasted for several months.
  • Regardless of the diagnosis and medical advice, the patient initially refused therapy, and proctocolectomy was delayed for 12 months.
  • At the time of colectomy, advanced tumor stage was diagnosed and classified as pT3c(4) pN1(2/120) M0 V1 R0, UICC stage IIIB, G2.
  • [MeSH-minor] Adult. Appendiceal Neoplasms / pathology. Cystadenoma, Mucinous / pathology. Humans. Male. Neoplasm Staging. Neoplasms, Multiple Primary / pathology

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Ulcerative Colitis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Zentralbl Chir. 2015 Dec;140(6):624-6 [25076166.001]
  • (PMID = 18842350.001).
  • [ISSN] 0344-0338
  • [Journal-full-title] Pathology, research and practice
  • [ISO-abbreviation] Pathol. Res. Pract.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


96. Fernández-Cebrián JM, Gil P, Hernández-Granados P, Fiuza C, Ochando F, Loinaz C, Rueda JA, Lasala M, Jiménez-Almonacid P, Vega D, Pardo M, Quintans A: Initial surgical experience in laparoscopic total mesorectal excision for middle and lower third rectal cancer: short-term results. Clin Transl Oncol; 2009 Jul;11(7):460-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Initial surgical experience in laparoscopic total mesorectal excision for middle and lower third rectal cancer: short-term results.
  • INTRODUCTION: Total mesorectal excision (TME) of the rectum has been advocated as the gold standard surgical treatment of middle and lower third rectal cancer.
  • METHODS: One hundred and thirty-two patients with middle or inferior rectal cancer were admitted to our unit and underwent TME from December 1998 to February 2008.
  • RESULTS: In the laparoscopic group 80 anterior resections (including 4 intersphincteric resections and manual colo- anal anastomosis) and 9 abdominal-perineal resections were performed.
  • Concerning adequacy of oncologic resection, mean distance of the tumour from the anal verge was 4.3+/-2.2 cm.
  • CONCLUSIONS: Laparoscopic approach for rectal tumour is a technically demanding procedure, but it is oncologically safe.

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Surg Endosc. 2005 Jul;19(7):892-6 [15920688.001]
  • [Cites] Dis Colon Rectum. 2003 Aug;46(8):1047-53 [12907898.001]
  • [Cites] Surg Endosc. 2004 Oct;18(10):1457-62 [15791369.001]
  • [Cites] Br J Surg. 1982 Oct;69(10):613-6 [6751457.001]
  • [Cites] Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005200 [17054246.001]
  • [Cites] Lancet. 2005 May 14-20;365(9472):1718-26 [15894098.001]
  • [Cites] Lancet. 2004 Apr 10;363(9416):1187-92 [15081650.001]
  • [Cites] Surg Endosc. 2005 Jun;19(6):757-66 [15868256.001]
  • [Cites] Int J Colorectal Dis. 2006 Oct;21(7):652-6 [16463181.001]
  • [Cites] Surg Endosc. 2002 Jan;16(1):7-13 [11961595.001]
  • [Cites] Ann Surg. 2003 Mar;237(3):335-42 [12616116.001]
  • [Cites] Dig Surg. 2007;24(5):367-74 [17785982.001]
  • [Cites] Dis Colon Rectum. 2007 Sep;50(9):1324-31 [17665258.001]
  • [Cites] Ann Surg. 2009 Jan;249(1):82-6 [19106680.001]
  • [Cites] Surg Endosc. 2005 Nov;19(11):1468-74 [16222464.001]
  • [Cites] Dis Colon Rectum. 2000 Jan;43(1):1-8 [10813116.001]
  • [Cites] Ann Surg. 2008 Apr;247(4):642-9 [18362627.001]
  • [Cites] Surg Endosc. 2004 Nov;18(11):1592-6 [15931488.001]
  • [Cites] Dis Colon Rectum. 2000 Nov;43(11):1503-11 [11089583.001]
  • [Cites] Cochrane Database Syst Rev. 2008 Apr 16;(2):CD003432 [18425886.001]
  • [Cites] Surg Endosc. 2004 Feb;18(2):281-9 [14691716.001]
  • [Cites] Dis Colon Rectum. 2005 Oct;48(10):1858-65; discussion 1865-7 [16086223.001]
  • [Cites] Dis Colon Rectum. 2007 Dec;50(12):2047-53 [17906896.001]
  • (PMID = 19574204.001).
  • [ISSN] 1699-3055
  • [Journal-full-title] Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
  • [ISO-abbreviation] Clin Transl Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


97. Schreurs LM, Verhoef CC, van der Jagt EJ, van Dam GM, Groen H, Plukker JT: Current relevance of cervical ultrasonography in staging cancer of the esophagus and gastroesophageal junction. Eur J Radiol; 2008 Jul;67(1):105-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Current relevance of cervical ultrasonography in staging cancer of the esophagus and gastroesophageal junction.
  • PURPOSE: To evaluate the value of external ultrasonography (US) of the neck in current dedicated preoperative staging of patients with cancer of the esophagus and gastroesophageal junction (GEJ).
  • MATERIALS AND METHODS: We analyzed 180 consecutive patients (154 men, 26 women, and mean age 63 (38-84) years) without palpable cervical lymphadenopathy, treated between January 2001 and March 2006.
  • CONCLUSION: In present staging procedures for esophageal cancer, routine external US seems to have no additional value in detecting cervical metastases.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Neoplasm Staging. Reproducibility of Results. Sensitivity and Specificity

  • Genetic Alliance. consumer health - Cervical cancer.
  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17681735.001).
  • [ISSN] 0720-048X
  • [Journal-full-title] European journal of radiology
  • [ISO-abbreviation] Eur J Radiol
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  •  go-up   go-down


98. Dengel LT, Slingluff CL Jr: Short length of stay and rapid recovery to normal function after surgery for metastatic melanoma to abdominal and retroperitoneal viscera. J Surg Oncol; 2009 Nov 1;100(6):481-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Short length of stay and rapid recovery to normal function after surgery for metastatic melanoma to abdominal and retroperitoneal viscera.
  • BACKGROUND: Metastatic melanoma to abdominal and retroperitoneal viscera carries a poor prognosis possibly resulting in reluctance to offer surgical management.
  • METHODS: Review of a prospectively maintained database identified patients with metastatic melanoma to abdominal or retroperitoneal viscera who underwent surgery from 9/99 to 8/06.
  • RESULTS: Nineteen patients underwent surgery for metastasis to abdominal or retroperitoneal viscera detected by clinical symptoms (80%), or imaging (20%).

  • MedlinePlus Health Information. consumer health - Melanoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19653258.001).
  • [ISSN] 1096-9098
  • [Journal-full-title] Journal of surgical oncology
  • [ISO-abbreviation] J Surg Oncol
  • [Language] eng
  • [Grant] United States / NHLBI NIH HHS / HL / T32 HL007849; United States / NHLBI NIH HHS / HL / T32 HL007849
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS810935; NLM/ PMC5010427
  •  go-up   go-down


99. Surprasert P, Khunamornpong S, Srisomboon J: Clinicopathological features and prognosis of Thai women with endometrioisis-associated ovarian carcinoma. Asian Pac J Cancer Prev; 2006 Oct-Dec;7(4):638-40
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This study was undertaken to evaluate the clinical features and survival outcomes of ovarian cancer patients who had associated pelvic endometrioisis.
  • The medical records of 1076 patients with ovarian cancer treated at Chiang Mai University Hospital between 1995 and 2005 were reviewed.
  • The most common presenting sign and symptom was an abdominal mass (12), followed by abdominal pain (10), abdominal distension (7), abnormal uterine bleeding (2).
  • In conclusion, most patients associated with endometriosis- associated ovarian carcinoma present with abdominal masses and pain.
  • Clear cell CA is the most common histology in ovarian cancer patients who have associated endometriosis.

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17250443.001).
  • [ISSN] 1513-7368
  • [Journal-full-title] Asian Pacific journal of cancer prevention : APJCP
  • [ISO-abbreviation] Asian Pac. J. Cancer Prev.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Thailand
  •  go-up   go-down


100. Li CC, Yang CR, Yu CC, Chen CS, Cheng CL, Ou YC, Ho HC, Hung SW, Li JR: Hepatic failure-induced hypogonadism in a prostate cancer patient. J Chin Med Assoc; 2010 Jul;73(7):389-92
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hepatic failure-induced hypogonadism in a prostate cancer patient.
  • Hypogonadism owing to systemic diseases in prostate cancer is rare.
  • Here, we present a patient with metastatic prostate cancer to the pericardium who had low serum testosterone level due to hepatic failure.
  • Perioperative intra-abdominal inflammatory process caused subsequent cholestasis and hepatic dysfunction.
  • Transrectal ultrasound-guided prostate biopsy confirmed prostate cancer.

  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • Hazardous Substances Data Bank. TESTOSTERONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2010 Elsevier. Published by Elsevier B.V. All rights reserved.
  • (PMID = 20688306.001).
  • [ISSN] 1728-7731
  • [Journal-full-title] Journal of the Chinese Medical Association : JCMA
  • [ISO-abbreviation] J Chin Med Assoc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China (Republic : 1949- )
  • [Chemical-registry-number] 3XMK78S47O / Testosterone; EC 3.4.21.77 / Prostate-Specific Antigen
  •  go-up   go-down






Advertisement